r/PEDsR • • Mar 04 '21

YK11 - What More Plates More Dates Gets Wrong NSFW

124 Upvotes

Recently I've seen a ton of people insisting YK11 is an orally available DHT derivative because of a shitty article written on More Plates More Dates. The purpose of this post is to explain how that article's claims rely on a combination of overreaching, straight up misunderstandings, and a piss poor understanding of chemistry.

As a reference, for anyone unfamiliar with steroid labeling, here's a convenient chart. If I refer to 5/17/19 etc. positions, I'm referring to the spots on the example steroid in that graph.

Now, MPMD makes two primary arguments as to why YK11 is a DHT derivative. The first relates to structural similarity, and the second has to do with how it's synthesized / poor reading comprehension.

First, Derek says "YK11 clearly has the same chemical backbone as Testosterone and DHT ". This is somewhat true - YK11 does have a steroidal backbone. However, the primary feature distinguishing testosterone and DHT is that DHT is 5a-reduced - there is no double bond between the 4 and 5 positions and an extra hydrogen atom hangs off at the 5 position. If one looks at YK-11, you'll see a double bond between the 4 and 5 positions.

All DHT derivatives lack that double bond - all of them. This includes stanozolol (winstrol), drostanolone (masteron), oxymetholone (anadrol), oxandrolone (anavar), DHB/1 Testosterone, etc. and any others you can come up with

If you look closer at YK, you'll also notice a hydrogen at the 19 position. This is the key feature of "19-nors", such as nandrolone (19-nortestosterone). If you don't want to trust me that YK11 is a 19-nor, you can hopefully trust the researchers in this paper on YK11 metabolism, who state:

YK11 also exhibits a 19-nor-steroidal nucleus.

Secondly, MPMD claims YK11 is synthesized using DHT: "Upon reviewing how YK11 was prepared, it appears to involve a combination of DHT, Hydroxyflutamide, ascorbic acid, and β-glycerol phosphate". However, he didn't review shit - he just misread two sentences in the paper he references:

YK11 was prepared as previously reported.(24) DHT, hydroxy flutamide (HF), ascorbic acid, and β-glycerol phosphate were obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

If you read the paper on YK11 preparation in reference 24, you will find that DHT was not involved in the synthesis (nor were hydroxyflutamide, ascorbic acid, or glycerol, which are not used in any steroid synthesis that I know of). The DHT and hydroxyflutamide were bought for the in vitro study; DHT was used as a reference to compare with YK11, and hydroxyflutamide was used to assess the effects of an anti-androgen in combination with YK and DHT. The vitamin C and glycerol were only used to prepare the osteoblast cell cultures for the study.

Lastly, MPMD makes the claim that " YK11 features a methyl ester which inhibits its hepatic metabolism and is what makes it orally bioavailable". However, a methyl ester is not the same as a methyl group - your standard orally bioavailable (BA) methylated steroid has an extra CH3 hanging off at the 17 position, not a carboxylic acid methyl ester hanging off at the 21 position.

The only paper on human consumption of YK11 suggests that it is rapidly and completely metabolized, with none of it being excreted unchanged. Searching around the internet, it seems that many bioavailable, metabolism-resistant steroids, such as oxandrolone and prednisone, are excreted partly unchanged, further casting doubt on MPMD's oral BA claims. Finally, the authors themselves note:

Due to its steroidal backbone and the arguably labile orthoester-derived moiety positioned at the D-ring, substantial metabolic conversion in vivo was anticipated

This doesn't mean YK11 is orally inactive. However, it does suggest that a large portion of what hits your bloodstream, or possibly everything that hits your bloodstream, may not be YK11 anymore if taken orally. Ultimately we will not know whether or not this is the case without more extensive in vivo studies.

Finally, I just want to mention that, to the best of my knowledge, we can't really make any claims about how suppressive etc. YK is based on other 19-nors. In theory, in vitro studies suggest YK11 might be one of the least suppressive steroids/SARMs out there because of it's unique gene-selective androgen receptor binding. However, the fact that it's metabolized into a variety of novel 19-nor progesterone derivatives of unknown activity means we cannot make any reasonable guesses.

tldr; YK11 is a 19-nor steroid, not a DHT derivative, with questionable oral bioavailability that is metabolized into a bunch of novel 19-nor progesterone derivatives of unknown activity. Anyone that tries to extrapolate its properties based solely on its structure is probably trying to sell you something.

Update as of a few hours after writing this post: MPMD has corrected the error where they misread the cited paper. They still compare it to DHT relentlessly, but use anecdotes as their justification, which is more reasonable. Also removed the oral BA part


r/PEDsR • • Dec 21 '19

Case Report: Lymphoma After Cardarine Use NSFW

62 Upvotes

I have a serious warning/anecdotal experience that I believe is one of the first to be reported in regards to very popular PED.

That's the first message I received about a week from anon.

I tend to get a couple of messages every day on Reddit, which I welcome and am happy to help folks out with where I can. My first thought was that it must be another user with elevated blood pressure, gyno, or experiencing hair thinning, or any number of common ailments. As I kept reading, it was clear that this is far from a common issue.

The Patient

  • Male, 20-30s

  • Self-described having good fitness genetics, and is up on his cardio

  • No issues throughout childhood

  • Good diet and no history of being an obeast

  • No family history of cancer or other major illness

  • Moderate alcohol consumption starting around 16 years old, and used painkillers, marijuana, and adderall on occasion (prescribed). Nothing like this was consumed on cycle, however.

  • PEDs experience is limited to 2 cycles

    • 1st Cycle: LGD4033 5mg/day for 8 weeks, Cardarine 10mg/day for weeks 4 weeks

    • 2nd Cycle: Test C 500mg/week for 12 weeks, Cardarine 10mg/day 8 weeks

Symptoms

The 2nd cycle had gone well up until the final couple of weeks, with anon setting PRs and otherwise feeling great. Only thing of note was he started seeing some blood pressure early on in the cycle, which is why he added in Cardarine. During the 5th week onward, anon upped the cardio and was running or walking on an incline for 3 miles a day, rarely missing a single day, while also lifting 5-6 times a week.

Towards the end of the cycle, anon started noticing a pain in his armpit. Fast forward two months: three ultrasounds, antibiotics for weeks, tons of blood work and hospital visits all leading to two auxiliary lymph nodes being removed, a biopsy performed, and a pathology report showing that anon has Lymphoma.

Symptoms started with lethargy, which he initially thought was e2 related but which blood work showed was within range. At some point after the cycle, anon got sick(er) - couldn’t sleep, feverish symptoms and then he noticed the lump in his armpit - hot and painful to touch.

Understandably, anon put this down to something related to the fever - swollen glands, blocked pores, acne, etc. This started a very drawn out process of determining what the cause was, which he (correctly) self-diagnosed as an inflamed lymph node. Anon saw a doctor, determined that it was indeed a lymph node, and an ultrasound determined it was two lymph nodes that were reactive. 99% of the time this means absolutely nothing - just something your body needs to fight off. All his other symptoms at this time had passed. A lot of blood work was done, which all came back within range.

During the next two months anons symptoms kept coming and going, which specifically were lethargy, poor appetite, losing weight rapidly. Eventually they said it was long enough and the nodes definitely had to come out. It was at this point after removal that he was diagnosed with lymphoma.

Moving Forward

Anon begins chemotherapy and radiation soon. Success rate is pretty high with this type of cancer, but there is still a chance that this could be fatal.

Anon is scared, in shock, and from his own assessment is a good person with a good life. He describes his emotions ranging from anxiety, regret and depression.

Coincidence?

Was anon always going to get cancer due to some unknown cause, risk factor, or due to random chance?

It's impossible to tell, of course, and I am wary of making conclusions. But that said, it would be foolish to ignore the presence of Cardarine.

Beyond sympathizing for this young man, the take away for me is a reminder that none of us are supermen, much as we would like to be. Bad things happen to good people, and we're no exception. The risks of taking PEDs are real.

Remember to hug your loved ones this Christmas.

--

For those finding this article and sub for the first time with limited PEDs experience/exposure:

What is Cardarine?

Cardarine was developed as a therapeutic agent and abandoned due to toxicity issues most likely related to its mechanism of action. Cardarine is associated with a higher rate of numerous cancers and a high frequency of reproductive toxic effects in preclinical settings. These animal studies (usually performed in parallel with early clinical development) resulted in termination of the clinical development program. The increase in tumour development was not replicated in the early human studies, which used lower doses and shorter study duration, so long-term effects in humans are unknown.

It's carcinogenic probably via its method of action (PPAR-d agonism).


r/PEDsR • • Nov 03 '19

Ashwagandha: Improves Male Health + Mental Health NSFW

61 Upvotes

Compiled by /u/RonaldomcDonaldo1, edited by me.

Ashwagandha tends to come up pretty frequently, and there's many anecdotes of its effectiveness, especially as a noot or in supplement circles, but rarely within the /r/PEDs community.

TL:DR Ashwagandha improves sperm count, improves testosterone (without impacting e2), improves LH, improves erections, relieves stress, decreases anxiety and led to strength gain in untrained group.

Disclaimer: I have no background in biology, chemistry, pharmacology, medicine etc. Any data presented is not advice, and I do not advocate the use of any illegal compounds. I have a potential conflict of interest: retail sale of related products.

Increased Sperm Count & Testosterone

46 men with low counts of sperm took a dose of 675mg 3 times daily over 90 days. There was a 167% increase in sperm count, 53% increase in semen volume, and 57% increase in sperm motility on day 90 from baseline.

In this same study, serum testosterone increased significantly by 17% (from 4.45 ± 1.41 ng/mL to 5.22 ± 1.39 ng/mL) and LH by 34% (from 3.97 ± 1.21 mIU/mL to 5.31 ± 1.33 mIU/mL), following treatment with Ashwagandha root extract, as compared to baseline.

Similar finding is also shown in rats: In addition, the non-diabetic Ashwagandha-treated group, serum progesterone, testosterone and the LH levels had increased significantly when compared to the control group (Figures 2, 3 and 4).

Interestingly, given the positive relationship of Ashwagandha with LH & sperm motility, we would expect FSH to also increase, but that's not the case: the serum level of the FSH level has been significantly decreased (p<0.05) in the Ashwagandha-treated group.

Erectile function also improved

Strength gain

In 57 healthy men aged 18-50, 600mg of Ashwagandha per day for eight weeks was administered and had a significant effect on strength:

  • Bench increased by 46kg, compared with the control group 26.4kg

  • Greater arm muscle size of 8.6cm, compared with 5.3cm with placebo

  • A difference of 2% in body fat between the two groups

These are pretty staggering numbers, and I have to think this group was completely untrained. For the placebo to gain a whole 2 inches on arms still makes me doubt how well this study can be applied to a group such as this community.

Stress, Anxiety and Depression

Ashwagandha is commonly used otc for those with depression / anxiety - my wife uses it herself for this reason and I can attest to the improvements many others also report on - I've been considering using it myself.

On completion of 60 days of treatment, there was only a 5.5% reduction in baseline stress scores in the placebo group, compared to 44.0% in the Ashwagandha group. While easy to write off as a placebo, it could also be explained by the incredible change that ashwaganda has on on cortisol, decreasing it in the subjects by 27.9%.

In a study looking at anxiety 75 folks were followed for 8 or more weeks. Final BAI (Beck Anxiety Inventory) scores decreased by 56.5% (p<0.0001) in the Ashwagandha group and 30.5% (p<0.0001) in the psychotherapy intervention group... significant differences between groups were also observed in mental health, concentration, fatigue, social functioning, vitality, and overall quality of life with the NC group exhibiting greater clinical benefit. No serious adverse reactions were observed in either group.

In rats, a comparison was done between Ashwagandha with common anti-depressants lorazepam (Ativan) and imipramine (Tofranil). 30 minutes after administering the dose the rats were put through a maze, had them interacting socially (whatever that means for a rat), and forced swam. The conclusion is that Ashwagandha worked on depression and anxiety as well as either of the two anti-depressants in this study.

Recommended Dose & SX

Around 500mg-750mg 3x daily seems to be effective without any significant side effects. Non-significant side effects include stomach pains, diarrhea, and vomiting.

So What?

I personally like this compound for the potential LH benefit it could bring to suppressed individuals. As something to be used toward the end of a cycle and then continued off-cycle, I could see it being beneficial however marginal improvements may be. At the very least, the improvements in anxiety and depression will help stabilize your mood during difficult post cycles.


r/PEDsR • • Oct 11 '19

Liver Impacts of SARMs NSFW

56 Upvotes

Disclaimer: I have no background in biology, chemistry, pharmacology, medicine etc. Any data presented is not advice, and I do not advocate the use of any illegal compounds. I have a potential conflict of interest: retail sale of related products.

The most common bro-science on if popular SARMs can have a negative impact to the liver ranges from ‘maybe’ to ‘categorically not’. Looking at the data from human trials, there is evidence that for some folks least liver enzymes can be increased. Understanding why is a little more challenging and there may be underlying causes. This article will look at data for some of the most common SARMs to evaluate potential hepatotoxicity.

Ostarine

At a sample size of 120 and a dose of 3mg:

Although transient increases in ALT to above the upper limit of normal were observed in eight subjects in this study, the ALT observations in seven of eight subjects had resolved while on drug such that no subject had clinically significantly, abnormal levels of ALT or AST at the end of study. One subject was discontinued due to an elevation in ALT 4.2 times the upper limit of normal. The ALT level in that subject returned to normal levels after discontinuation of the study drug.

Here at least is some evidence that Ostarine may cause increases in liver values, with ~15% of the sampled population increasing ALT during a relatively low dose of Ostarine. This could be dose dependent increases in liver values (i.e. it is mildly hepatoxic and requires higher doses for it to have a measurable effect) or genetic variability (i.e. only certain folks have a negative reaction), I’m not sure which - see causes below.

LGD4033

In the LGD4033 trial, there were no clinically significant changes in liver enzymes, hematocrit, prostate-specific antigen, or electrocardiogram at any dose. The raw data on liver values is not available to support this claim (I looked) so we’ll have to take the researchers at their word that at 1mg there were no significant changes in ALT, AST. Kidneys (BUN, Creatinine) were apparently not looked at.

YK11

Annecdotes suggest it is hepatoxic, with broscience being that it’s because it’s methylated - the full formula is (17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester. We don’t have any human data, so at this point everyone should be aware that YK11 likely elevates ALT and AST.

Alylated AAS

Not the focus of this article, but it’s pretty well known that alkylated AAS are pretty much without exception hepatoxic. 17 alpha alkylated steroids are (usually) taken orally and metabolized in the liver. The slow clearance of these compounds makes them hepatotoxic, characterized by elevated liver transaminases (ALT, AST), acute cholestatic syndrome, chronic vascular injury, hepatic tumors, changes in lipoproteins and toxicant-associated fatty liver disease. Examples of 17 alpha alkylated steroids include fluoxymesterone, methyltestosterone, oxandrolone, stanozolol. A comprehensive list is available here.

Significance of ALT & AST

ALT and AST are good markers for detecting inflammation, and easy to detect. However, these markers don’t just show liver inflammation, and muscle inflammation can elevate them too. The way to distinguish between muscular inflammation or genuine hepatic distress is the ratio of the two - AST should be approximately 0.8 of ALT level (AST * 0.8 = ALT). Once elevated from muscular inflammation, levels can be expected to stay elevated for about a week.

Can regular exercise elevate ALT & AST beyond normal levels? Anecdotes suggest yes, with user blood work from the main sub showing this - I think particularly of an instance of a middle-long distance runner (5k-25k) who shared his bloods with ALT & AST way out of range the day after a race, which returned to normal within a few days.

Other potential causes of liver transaminase elevations include viral hepatitis, alcohol use, medication use, steatosis or steatohepatitis, and cirrhosis. Common health conditions, such as diabetes, heart disease, and thyroid disease, can cause or augment liver transaminase elevations.

What Causes Liver Toxicity?

In a healthy adult, the liver weighs about 3lbs (not relevant, just interesting) and helps purify the blood by changing potentially harmful chemicals into harmless ones. The sources of these chemicals can be outside or inside the body (for example, ammonia, which is produced internally from the break-down of proteins; or bilirubin, which is produced from the break-up of hemoglobin). Hepatoxicity is categorized into three areas: dose-dependent toxicity (think high doses of tylenol, for example), idiosyncratic toxicity (genetic), and drug allergy (immune system attacks drugs in the liver).

When considering the effect that Ostarine had on the liver, it’s not clear due to which of the above it falls into. Or it could be none and be related to either subjects lifestyle and diet (though I would have expected this to also be the case with LGD4033), or increased inflammation from higher intensity workouts.

What Else Causes Liver Toxicity? - Androgen Receptor Activation

One potential cause of hepatoxicity is the activation of the androgen receptor. In one experiment, researchers recorded an increase in reactive oxygen species (a build up of which can kill local cells) after addition of methyltrienolone, a synthetic 17α-alkylated AAS. Addition of an AR antagonist (bicalutamide) reduced it, suggesting an androgen receptor mediated effect.

If this theory is proven conclusively, it would give us a new understanding - a compounds resistance to metabolism and potency to induce AR transactivation in the liver can determine hepatotoxicity. When adding a double bond to a compound, for example, which presumably increases the amount of resistance to metabolism, it seems to increase hepatotoxicity even at low dosages. In anavar, which is resistant to being metabolised, it's low affinity for the androgen receptor makes it more liver friendly than other similar AAS.

TL:DR anything that is resistant to being easily metabolized and activates the androgen receptor is going to cause hepatoxicity, in addition to the three primary reasons above. What ‘easily metabolized’ I hear you say? I have no clue.

So What?

My conclusion agrees that most SARMs (LGD4033, Ostarine) are well tolerated with infrequent transient increases in ALT. There is, however, a subset of users that seem to be susceptible to increases in ALT, and I’m unclear if this is related to dose, genetics, AR activation etc. Causes of elevated ALT may also be completely unrelated to SARM use, some kind of sensitivity, be associated with increased exercise / muscle growth. I do think it’s prudent to consider your liver health prior to using any SARM, Ostarine in particular, and even utilize herbs such as milk thistle to improve liver health on cycle.


r/PEDsR • • Aug 18 '19

PEDs as an Addiction NSFW

52 Upvotes

Disclaimer: I have no background in biology, chemistry, pharmacology, medicine etc. Any data presented is not advice, and I do not advocate the use of any illegal compounds. I have a potential conflict of interest: retail sale of related products.

This article is prompted by my own problem with PEDs, which is very simple: I hate being off cycle. Recently, I re-evaluated my own goals and am attempting to stop or scale back my use of drugs across the board. As of publish date, I am using HCG and HGH, and planning on switching to enclomiphene in a few months time. The ‘weaning protocol’ is worth diving into, and I'll cover that another time once I have data (bloods) to start sharing. But this article isn’t about me.

Addiction to PEDs is often masked by a YOLO attitude, all too present in our brommunity. Not surprising really since many PEDs reduce inhibition.

So why should we care? I look fabulous

AND

Whatever bro, you can be addicted to anything

Both points are probably true. You do look fabulous (no homo), and you can be addicted to anything. But let’s be real - PED use can absolutely be an addiction and it’s something we ignore or, worse, often applaud.

What is Addiction?

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors.

Addiction is characterized by inability to consistently abstain... Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.

My bold: the pursuit of physiological improvement at physical cost. In our context, the reward is getting swole.

Case 1: Rats Wanna Get Swole Too

Testosterone increases dopamine and serotonin. Testosterone also seems to be rewarding to the organism its applied to, with rats display(ing) a preference for an environment previously paired with (testosterone) administration as opposed to an environment paired with saline administration.

Case 2: Dallas McCarver

Died August 2017, 26 years old. Autopsy uncovered the following:

  • Severe cardiomegaly - a 833 gram heart, with left ventricular hypertrophy. For comparison, a normal heart is 300 grams... this is the reason of death listed on the autopsy report, with artery sclerosis aka plaque buildup as a contributing factor.

  • Heavy lungs - 1.5 times normal size

  • Liver - 3 times normal size

  • Kidneys - enlarged

  • Thyroid carcinoma

Known to have used AAS, HGH, IGF, Insulin.

Guy had some warning that things weren’t OK... previous collapse and cardiogram. Seemed predisposed to LVH - even knowing this and prior warning, he persisted with exogenous hormone use.

Case 3: Rich Piana

I’m sorry... it’s too soon... I just can’t

Case 4: Zyzz

WHY, GOD WHY? Died August 2011, from an apparent heart attack. Autopsy revealed congenital heart defect. That, along with his high blood pressure and associated symptoms, were contributors.

See you on the other side, brah

PEDs as an Addiction

In the 3 latter cases above, subjects had warning. One of the easiest symptoms to detect something is not right is monitoring high blood pressure. In multiple cases, we see that patients continue ‘pathologically pursuing reward’ which results in death. Fits the definition of addiction perfectly.

Case 1 demonstrates that physical dependence is correlated with testosterone. Whether other PEDs have the same physical dependence, or it’s more psychological (look better, feel better, therefore I will keep doing it, but no cravings and no withdrawal), is probably irrelevant - we see much the same behavior with many compounds.

Is the devil in the compound? As in, is it just HGH, testosterone, IGF, and insulin that is the common thread here? I don’t think so - insulin can kill, but is not (physically) addictive. My speculation is it’s the long term use of any compound due to psychological addiction. After all, most PEDs will have severe health impacts if you run it long enough.

Abuse And Dependence

The following is an abridged extract of an article by Dr. Brower, available here. It makes the usual absurd links of linking steroid use to other risky behavior such as using amphetamines and sharing needles (!?) - why do researchers include ridiculous fringe use cases? - but it does quantify instances of dependence and proposes a 2 step model for addiction - muscle-active and psychoactive.

Anabolic-androgenic steroids have been associated with depression, mania, psychosis, suicide, and marked aggression leading to violence and homicide. Conversely, they have been used therapeutically to improve mood and alleviate depression. Either way, AAS are generally recognized by psychiatric researchers to have psychoactive properties.

In a previous review of the scientific literature published between 1988 and 1998, evidence was cited that AAS dependence is a diagnosable mental disorder. Between 1999 and 2000, two more diagnostic studies of AAS dependence were published including the second known instance of dependence in women. Altogether, the medical literature contains a total of at least 165 AAS users who met criteria for dependence. Therefore, AAS dependence is readily identifiable if one samples the right population and asks the usual diagnostic questions. A withdrawal syndrome from AAS has been described that can last for weeks to months, and consists of depressed mood, fatigue, a desire to take more AAS (craving), restlessness, anorexia, insomnia, and decreased libido. Many of these symptoms are the opposite of effects observed during AAS administration (hypomania and increased energy, appetite, and libido).

A new model of AAS dependence is proposed consisting of two stages to account for both the muscle-active and psychoactive effects of AAS. In Stage 1, high-dose AAS are used for their muscle-active effects in conjunction with strict dietary and intensive weight training regimens... In Stage 2, it is hypothesized that chronic, high-dose administration of AAS activates brain-mediated reward systems.

Something to Be Aware Of: Depression

143 Swedish athletes who competed in power-lifting, weight lifting, wrestling, shot put and discuss in the 60’s-80’s admitted to PED use. Respondents that claimed to use PEDs for 2 years or longer reported depression at about twice the national average: 11.2% compared to 6.7%.

Correlation doesn’t equal causation, so we can’t say for sure that PED use causes depression, just that there’s an association.

YOLO

Whatever bro, my vitals and bloods are fine

Good on you for monitoring your health and taking it seriously. Please keep doing it, and have the strength to stop when the warning signs start.

I'm doing it smarrt too. Running reasonable doses, and taking time off between cycles

Quick sidebar - within the Discord, there’s one user who I adore. He’s funny, deliberately controversial, and completely irreverent. Last I spoke with him, he was running a Rich Piana style cycle, at least by my own DYEL standards. When I and others pushed him on his cycle his reply was something along the lines of ‘I don’t want to live forever’. A pretty common sentiment, and I’ve heard it repeated before on bodybuilding.com and other places. ‘If PED use means I only live to 70, instead of 80, no big deal. YOLO.’

Except it’s not about living to 70, or 80, or 100. It’s about not stroking out at the age of 32, and relying on a feeding tube for the rest of your life. Or dying at 26 like Dallas did. Or dying in a sauna somewhere in a whorehouse.

The vast majority of people are not going to die from PEDs use. We all want to look like Zyzz brah, I just don't want you (or me) to die like him. Be honest with yourself about dependence, hard as it may be.


r/PEDsR • • Nov 10 '18

All Hail King Tren NSFW

52 Upvotes

TL:DR lack of human data forces some guesswork. Tren is highly anabolic, and has been shown to increase muscle size. Can cause mood swings, have a progesterone impact, and will impact cardiovascular health. Oddly, seems to increase attraction to Thai and Filipino ladyboys.

Tren was released for human consumption as trenbolone hexahydrobenzylcarbonate, with a big, throbbing & veiny long ester, and then ‘voluntarily withdrawn’ from the market in the 90s. Like we saw in DNP, a compound that is easily abused may be banned from the FDA in the US, which ultimately leads to it being withdrawn from the prescription market. It was anecdotally highly beneficial in its limited use case but unfortunately the clinical trial results have been more or less suppressed, and are written in some kind of code (french). Accordingly, I’m relying on clinical data from animals and inferences from broscience. I’m also speaking generally about tren and its esters (acetate, enanthate, undecanoate), and while there are some differences in effects this article is broadly applicable.

What makes Tren king is its versatility - give the high binding affinity and anabolic rating 5 times that of test , it offers advantage to cycles that look to preserve or add mass. It’s also lipolytic: Tren reduces fat while increasing muscle while otherwise at maintenance.

Tren binds to androgen receptors with 3 times the affinity of test. It is highly virilizing, inhibits spermiogenesis, and is more androgenic than test (interestingly, the research I’m citing here makes a claim that androgenicity and virilization seem to run parallel and that would make sense when we think of other highly androgenic and highly virilizing compounds, as well as the opposite, but I digress). Despite the high androgenic rating of 500 (test is the baseline of 100, making tren 5 times more androgenic), there is evidence that tren does not act as androgenic as the rating would imply, given research findings that tren does not have the same impact in organs as test:

17-TBOH (tren) exerts less pronounced effects than testosterone in androgen-sensitive tissues… Despite its inability to undergo 5(alpha) reduction, 17-TBOH remains highly anabolic.

This is demonstrated in Rat Study 2 below, and is due to tren not having as significant effect on tissue that express 5a reductase enzyme. This enzyme is what metabolizes testosterone into DHT, which has a strong binding affinity in areas such as the prostate which causes the undesirable side effect of tissue enlargement. Tren has either limited or no effect.

Medical Trials

Rat study 1: tren increased satellite cells (the precursor to skeletal muscle) by 178% compared compared to the neutered group. Oddly tren did not increase the number of myonuclei found in muscle (this generally happens before hypertrophy can occur), and myostatin was increased by 169% when compared to the neutered group but was lower than the unneutered control.

Rat study 2: dose dependent relation to fat loss is demonstrated, as well as improved bone density. At the lowest of doses, the neutered group did not increase prostate mass or hemoglobin, while improving skeletal muscle mass and lowered visceral fat. Researchers conclude that low dose tren only (without a test base) has its advantages over supraphysiological test and is an option for hormone replacement therapy.

Human studies are not really available: we are unaware of any paper that has reported the effects of 17-TBOH administration on the growth of androgen-sensitive tissues in humans. Given that rats are not a great analog for humans, especially where it comes to myonuclei, it’s not possible to make conclusive statements from the two rat studies. Or, for that matter, studies done in cattle or other mammals.

Side Effects - Actual

Mood swings: there are some undeniable effects of tren (beside getting swole) and a couple that I think we should be skeptical of. The first is the anecdotal evidence of its impact on mood which will vary. It’s not that it puts you in a bad mood per se, as it does have positive effects to the feeling of well-being that most PEDs do, but you might over-react to an unforeseen event. My personal experience is that trensomnia exasperates this side effect, and accordingly I recommend using sleep aids if you have tren in your cycle. I personally prefer CBD which is well tolerated and effective without straining kidneys, but /r/nootropics can recommend others if this is not suitable or available.

Progesterone: reliable data on tren and its relationship with progesterone receptors is lacking, however tren belongs to the nandrolone group of aas, which we know binds to the progesterone receptor with about 22% the affinity of progesterone. Ordinarily, men have very low levels of both prolactin (0.2ng/ml or less) and progesterone (1ng/ml or less). Even a small real increase in either, and there is a relationship between the two, will cause issues - specifically the growth of breasts. Nice. Prolactin and progesterone are both suppressed using cabergoline. B6 is also likely effective. Have either on hand during your tren cycle.

Cardiovascular health: Nandrolone, and tren which belongs in the same AAS family, put cardiac health is at risk. I’m using nandrolone as the proxy for tren, given lack of cardiovascular studies and the similarity in the compounds. Both will cause cardiac hypertrophy and result in poor LDL markers:

We found that 6 weeks of nandrolone treatment with or without accompanying physical training increased oxidative stress damage markers, unfavorable lipid profile, cardiac hypertrophy, fibrosis, and cardiac and coronary vessel proliferation in rats.

Oddly, this study demonstrated that nandrolone + cardio exercise (enforced swimming) actually worsened health compared to nandrolone + sedentary. It’s possible that the added stress of the type of exercise, which involves swimming until the rat starts to drown, had something to do with this and we should discount the fact that this study shows cardio worsened cardiac health. Either way, given that cardio was not shown to improve cardiac health in either of the nandrolone groups, diet then becomes the main variable that can the user can control to reduce impact to heart health and cholesterol levels.

On a positive note, tren is ‘relatively non-estrogenic’ and may have anti-estrogen effects in humans. It does possess an estrogen receptor binding efficiency of 20% of that of e2 which is not a problem as tren does not aromatize - there’s no conversion to DHT or e2. The implication of this is important later on in this article as it may support running tren only cycles: because tren binds to the estrogen receptor it may fill some of the role that e2 binding would ordinarily play.

Side Effects - Bro-science

There’s some broscience that tren is highly toxic to kidneys and/or liver and while tren is indeed metabolized in the liver, toxicity is low due to being administered intramuscularly (as opposed to orally or otherwise). I would not be overly concerned about this side effect unless running very high doses.

And on the topic of DHT - tren is reportedly devastating to hairlines, apparently due to its high androgenicity. But this doesn’t make sense from what we know of this compound - with no aromatisation comes no increase in DHT. No DHT means no acceleration of alopecia if predisposed:

In certain tissues, such as the prostate or in the hair follicles, testosterone is converted to dihydrotestosterone (DHT) by 5 alpha-reductase (5AR)... A critical role for DHT in hair growth can be seen in the case study of men with Imperato-McGinley syndrome. This condition results from a mutation in the gene for type II 5AR that prevents the expression of the enzyme. As a consequence, men with this condition never become bald.

My speculation is that that tren is not a contributor to hair loss, unless paired with a TRT or higher doses of test (say, 200mg or more every week). Given that tren is in the nandrolone group of aas, and that deca (also in this group) is ‘hair friendly’, I hold that this is more likely broscience than fact. That said, if you know better or have a link showing that tren / DHN does impact scalp androgen receptors, or the high binding affinity of tren affects scalp receptors in a novel way, or has some other action (such as displacing DHT ligands which causes a short term impact on hair) please share it with the bromunity - I’m happy to be wrong and post an update saying as much.

Sacred Cow: Tren must be paired with test

In multiple studies, researchers claim that tren is a potential candidate for hormone replacement therapy. One conclusion I found was especially poignant (paraphrased):

Tren prevents the alterations in body composition associated with losing ones testicles to the same extent as supraphysiological testosterone. Specifically, tren and supraphysiologic test produced equally myotrophic responses in both intact and de-balled animals, Tren partially prevented induced bone loss to roughly the same extent as supraphysiological test, and at equal doses, tren was somewhat more lipolytic (i.e. fat reducing) than test in visceral fat.

When you couple this conclusion with the lack of androgenic effect in the prostate, the binding to estrogen receptors, and the dose-gains relationship that rats shows on tren only cycles, this compound could theoretically be ran by itself. Tren will, however, result in shutdown via (presumably) HPTA feedback loop, leaving the individual in a low test state similar to a SARM or oral AAS only cycle, and would require PCT.

Conclusion

I’ve advanced two controversial ideas in this post, the first about tren not having an impact on hair loss and the second about tren only cycles being viable. It’s not my intention to be deliberately aggressive with these ideas for the sake of fake internet points, but rather the PEDsR mission is to learn, be curious, and question broscience wherever it is productive to do so. The one fact that cannot be disputed about tren is that with an anabolic rating of 500 it is incredibly effective at building and maintaining muscle. Be in a good place, mentally, before you run it.


r/PEDsR • • Apr 02 '19

"Temporarily" bad lipids may be worse than you think NSFW

49 Upvotes

NOTE: I'm not a medical professional of any sort and I have NO background or expertise in this area at ALL. This is NOT medical advice. This isn't intended to be advice at all. I'm providing my OWN PERSONAL NOTES here for educational purposes ONLY. You should consult with a physician and take THEIR advice.

As an additional note, I do NOT condone the use of illegal anabolic steroids or other illegal drugs. To put it briefly, I don't think you should do steroids or other anabolics outside of the care of a physician.


"The first principle is that you must not fool yourself - and you are the easiest person to fool." - Richard Feynman


You're going to die someday, and it's probably going to be heart disease that kills you.

"Heart disease" can mean a few different things, but for our purposes we'll take "heart disease" to mean coronary artery disease / atherosclerosis ("CAD"), e.g. the gradual accumulation of plaque in arteries. When most people think of CAD they think of something you suddenly "have" rather than a slow process that occurs over years. In reality, atheroscleroic plaques begin to accumulate in early childhood, and by age 10 almost all children have fatty streaks in their arteries[1]. Sub-clinical CAD can exist for many years before clinical symptoms of heart disease, such as hypertension, present themselves.


Recommended reading: Peter Attia's series on cholesterol

I highly recommend reading M.D. Peter Attia's blog series on cholesterol which can be found here:

That being said, the blogs are long and take some serious attention to process. They're worth it, though.


Bad lipids are bad

What I've learned from reading the above posts (besides the different values that can be measured, e.g. LDL-P, HDL-C/P, etc) is that it looks likely that the main driver of atherosclerosis over time is area under the curve. E.g. not just the amount of time you spend with some atherosclerosis-inducing cholesterol ratio, but rather the magnitude of those lipids summed over time [2].

As I dug further, I found more evidence that this area under the curve should be a worry for folks. E.g. https://www.fightaging.org/archives/2018/10/can-atherosclerosis-be-prevented-via-early-large-reductions-in-ldl-cholesterol/, https://www.heart.org/en/news/2018/10/04/researchers-suggest-way-to-possibly-eliminate-artery-clogging-condition, https://www.ahajournals.org/doi/10.1161/JAHA.118.009778 (REALLY interesting).

So what's incredible here is that there's researchers testing the following: they take somewhat younger people, e.g. 35-50 years old, and give them statins to lower their LDL-C down to <= 25 for > 1 year. Then they take these people off the statins, have them go off and lead a normal life and then measure their cardiac risk over time. The theory is that this sustained period of ultra-low LDL allows "HDL" (& associated machinery) to possibly clean up early aterial plaque development before it progresses. So in these peoples' cases, their "curve" would dip down into the 'negative', hopefully allowing them prolonged life/health span.

Of course we don't know whether or not this will work, but what stuck with me in this reading is that the classic picture of "getting" heart disease or being of sufficient age / bad cholesterol levels to require e.g. statin treatment almost certainly comes too late to stop the progression of atherosclerosis.

So how's this effect PED usage? Well obviously a ton of anabolics jack up LDL-C and lower HDL-C, which likely leads to a "tall" y-value in this "area under the curve." Lots of guys "cruse," reducing their anabolic dosage for some period of time to "let their blood recover." But it seems a drastically more aggressive approach could be helpful to users of anabolics.

We don't really know what these studies will show us, but it could mean that guys should aim for ultra-low LDL values for sustained periods of "cruising," values FAR beyond what exist in the typical western population. The common perception is that bad lipid elevations are benign, akin to something like temporary liver enzyme elevations. This may not be true.

And no, "sustained period" here does NOT mean "time on = time off." Think of what the curve looks like. Here's your typical person who develops clinical CAD in his 40s and dies of a heart attack:

https://ibb.co/x5v9W4c

The red line is where he dies. At the point where the red line is, his Total Cholesterol: HDL-C [3] ratio is 7 and he's not on a statin.

And here's someone who's healthy and lives to 85 and then suffers from congestive heart failure secondary to CAD:

https://ibb.co/cT2hPMz

The red line is where he dies. At the point where the red line is, his Total Cholesterol: HDL-C ratio is 2.5 and he's on a statin.

And here's someone who's 55 years old, is otherwise healthy but did a couple of AAS cycles:

https://ibb.co/4fC4XwQ

This graph isn't quite right but you should hopefully get the idea. The red line is where he dies. At the point where the red line is, his Total Cholesterol: HDL-C ratio is 3 and he's not on a statin. He eats right, does his cardio and checks his lipids regularly.


But the key is:

  1. Lipids are a "snapshot" in time. They tell you what some numbers are right now but they don't tell you about what happened before and the damage that was done.

  2. Standard lipid tests don't tell the whole picture, as detailed in the Peter Attia blogs. A bit more on this below.

  3. To see the "area under the curve" something akin to a coronary calcium scan ("CAC" or "heart scan") would be needed. See https://www.mayoclinic.org/tests-procedures/heart-scan/about/pac-20384686, https://www.youtube.com/watch?v=NSPcuGjstN4.

  4. Temporary "bad lipids" could have a sustained impact on lifespan due to accumulation of atheroscleroic plaque. This could be compounded by insufficient time on "cruise" or in recovery where lipids are good enough to "clean up" accumulation (e.g. with lipids as good as the AHA study above). "Standard" / "in range" lipids on "cruise" may be insufficient to "clean up" accumulation because CAD -- aka the reaper -- is coming for us all, it's just a matter of area under the curve. AND, in fact, it may be impossible to "clean up" the accumulation done by a period of bad lipids - we don't know!


Caveats here:

  1. I'm NOT an expert of ANY sort here. These are my OWN OPINIONS, SHARED FOR EDUCATIONAL PURPOSES ONLY.

  2. It's totally possible that "area under the curve" isn't quite right and there are other factors that correlate with age that lead to acceleration of CAD such as LDL receptor degradation with age.

Being that, again, I am NOT an expert or ANY kind of medical professional, what I've gleaned for myself from my recent reading is that the following tests are important to get:

There is lots of variability here so it's important to know what cards you're dealt genetically and the best way to do that is to get tested.

Personally, I'll be getting all of the above annually (sans Lp(a) which I tested just one). If I was an AAS user I would definitely get a CAC done to assess my "area under the curve."

Layne Norton just got a CAC done and found out he has calcified plaque in his arteries. The good thing is that he is seeing the impact NOW so that he can make changes to prolong his life. John Meadows had a CAC done last year and found out he has calcified plaque in his arteries.

Again, I am NOT an expert and I welcome any and all comments here. These are truly my own personal beliefs and notes, shared purely for educational and discussion purposes and are NOT advice.


Notes:

Some people think that the reductions in HDL-C on cycle don't matter as they won't contribute to an increase in atheroscleroic plaque. The evidence we have right now is that reductions in HDL-C with AAS are associated with atheroscleroic plaque and reduction of HDL function


Footnotes:

  1. https://www.youtube.com/watch?v=AkWd0R05ZEs, https://www.ncbi.nlm.nih.gov/pubmed/11063473, https://www.ncbi.nlm.nih.gov/pubmed/1619200, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812791/

  2. Note that we don't really know what this ratio is, which is part of the problem. LDL-P (which is ~LDL-C in most cases) seems to be an independent driver of atherosclerosis development. Figures I've read state that LDL-C <= 25 /may/ be "atherosclerosis-proof." I'm not sure if we know whether a good ratio does or doesn't drive atherosclerosis.

  3. FYI this is called the Castelli Index (TC: HDL-C) and it's the most-used general CAD risk marker. Of course, if you read the Peter Attia posts you'll see this does NOT paint the whole picture of CAD risk. But this is just an illustration and so I'm using the Castelli Index as a storytelling tool here.


r/PEDsR • • Apr 09 '20

Resurrecting PEDsR Database NSFW

48 Upvotes

Greetings, it's been a while.

Since the unfortunate demise of the PEDsR website and PEDsR database, I've known the inevitable next step is to rebuild the database. Over the past few days, I've put together a list of known ergogenic compounds (shamelessly stolen from MrHappy's discord list, thanks Happy) and am going compound by compound filling in the blanks. There's a lot of compounds to do, and a lot of info to find. I estimate I'll be completed at some point in May.

There is a silver lining in the loss of the original database - it can be rebuilt from scratch to do more. Specifically, I want the database to become a spot where most questions can be answered. For example:

  • Should I run an AI alongside LGD4033?

    • The database says no.

  • What bulking compounds can I use that don't raise blood pressure.

    • The database shows me 4 compounds I can choose from

  • What compound has a low enough mass that I can make a topical application?

    • The database shows a bunch

  • What compounds does the WADA have a test for?

    • All of them, you're fucked

And so on and so forth.

I've thrown it up on www.pedsr.com in a temporary state. I'd make the spreadsheet available for download / edit / comments once I have it mostly completed.

If you're willing to navigate the clunky embedded Google Sheet, feedback and criticism is always welcome.


r/PEDsR • • May 14 '19

Low Dose DNP as Medicine NSFW

46 Upvotes

In relation to peds DNP is usually associated with being extremely powerful with terrible risk/reward ratio. In march 2019 a paper was published by Mitochon Pharmaceuticals that shares some extremely disruptive ideas about DNP I would like to plagiarize summarize.

At the heart of the paper is the question “Is it possible that most, if not all neurodegenerative diseases are manifested through mitochondrial dysfunction?” the therapy is based off the premise that “It is possible to wake up redundant cellular compensatory mechanisms by modulating the mitochondria’s physiology towards survival of the cell, slowing aging, and the potential to prophylactically treat patients to entirely prevent the myriad of age-related illnesses."

Based on the mass of old human and more recent animal data the FDA has granted an open Investigational New Drug status to begin rigorous clinical testing of DNP for safety and tolerability, including for the first ever, pharmacokinetic profiling in humans. Exciting times, we will soon see if DNP it truly as promising as the authors believe.

Evidence supporting the therapeutic effects of DNP

The early immediate effects of DNP lower the mitochondrial membrane potential, which abolishes reactive oxygen species (ROS) production and subsequently closes the transporter involved in calcium influx. This is responsible for the acute effects of DNP. The downstream effects cause increased cAMP leading to a cascade resulting in the increase of BDNF causing long term changes.

Reactive Oxygen: DNP directly reduces ROS production, it also lowers NADH which further reduces ROS production and has significant health and anti-aging benefits.

Calcium Overload

Occurs after TBI, stroke, drug overdose and as part of many chronic diseases, leading to cell death. In studies DNP reduced levels of  ROSs and Ca2+ and resulted in increased survival of the injured areas.DNP may induce autophagy“Since DNP lowers the membrane potential, there is a theory that it might selectively push those already marginally functioning mitochondria into autophagy to shift the global mitochondrial population towards better functioning high ATP producers and lower ROS producers.”

ATP levels

At low doses glucose consumption was unaffected indicating that cells adapt to chronic respiratory uncoupling allowing continuous and efficient mitochondrial ATP production without the need to increase glucose consumption. So collectively, it is possible that the net outcome is a higher ATP pool through more efficient mitochondrial functioning under chronic DNP treatment, than could previously be generated without the uncoupler.

Neuroprotection

The same previously mentioned mechanisms have a powerful neuroprotective effect though changing ROS production, Ca2+ handling, autophagy, induction of BDNF and cellular remodeling. Very low doses of DNP equivalent to ~0.5mg protect short term memory and increases lifespan in Alzheimer’s model. DNP provided significant behavioral protection preserving grip-strength and motor skill coordination in animal model of parkinson's. Large doses of DNP are not neuroprotective.

Diabetes, Metabolic Syndrome and Fatty Liver Diseases

DNP prevented hepatic fat accumulation from high fat diet, DNP treated animals showed lower fasting plasma glucose, triglyceride, and insulin concentrations

Healthy way to use DNP (maybe)

The authors make the statement that “perhaps it is time for a paradigm shift from the lofty goals of weight loss, to a wellness program. Merging the 1930s data that suggested long chronic treatment can lower the glucose levels in obese individuals, with the idea that very low doses over long periods of time can have a striking effect on many endpoints, could be such a paradigm shift.” they suggest 2-22mg of DNP/day with the optimal dose likely being dependant on purpose ( neuroprotection is strongest at lowest doses equivalent to 2mg or less DNP per day.) This dose is 20-200x smaller than the doses used for weight loss, greatly expanding the drugs therapeutic window and minimizing side effects. I eagerly await the results of the human trials.

TL;DR Dose makes the poison


r/PEDsR • • Apr 03 '19

PEDs and cancer NSFW

46 Upvotes

Hi.

I hang around PED groups because of cancer.

In December of 2017, my mother was diagnosed with stage IV breast cancer. That's the kind where the doctors tell you "we'll keep switching treatments for a few years until you die, haha lol sucks to be you lmao." I thus began searching high and low for additional treatments that were backed by science.

To my surprise, there do not appear to be any communities interested in that sort of thing. Either they're the completely insane type that scream "THE CURE IS APPLE PITS PLUS COFFEE AND BLEACH ENEMAS, 10x DAILY", or they're the straight-and-narrow "the standard of care is the only thing you should ever consider thinking about doing" kind that are so jaded by the former that they will steadfastly refuse to think outside of the box.

Except for PED users. Apparently, I found my people.

I'm not a doctor, but I have probably spent upwards of a thousand hours at this point researching cancer. There's a significant overlap between many PEDs and cancer therapies, and people keep asking questions about potential cancer risks, so I'm going to try my best to share what I know on the subject.

Also, shameless plug: I shout into a mostly empty void on a subreddit where I collect my research: http://reddit.com/r/BreastCancerResearch

Bro, I'm in my 20s/30s, and cancer is the last thing on my mind.

Fair point. Cancer traditionally affects older demographics. And, it's no surprise that it affects unhealthy demographics moreso than healthier demographics, such as presumably who's reading this post. Not living like a vaguely human-shaped blob in a Pixar film about dystopian space Wal-Mart is a great first step to avoiding it. And the readers of this sub almost certainly eat more green vegetables than the average Wal-Mart shopper that ends up tragically tipping over their mobility scooter while reaching for the gallon jug of mayonnaise.

But the unfortunate, sad truth is that you're statistically likely to be impacted by cancer at some point in your life. Cancer is the second leading cause of death in males: https://www.cdc.gov/healthequity/lcod/men/2015/index.htm

PED use may impact this further, which is what we're going to dive into now.

But wait, bro, can't my enormous muscles, like, punch the cancer cells in their stupid little faces?

I wish. There are three primary cancer risk factors in PED use:

  1. Increasing the proliferation of an androgen sensitive cancer that already existed in the body.

An example of this is prostate cancer, which is is usually androgen sensitive, meaning that androgens may cause it to grow faster - and removing them may make them grow more slowly, which is why androgen deprivation therapy may be used as treatment: https://www.cancer.org/cancer/prostate-cancer/treating/hormone-therapy.html

However, increased levels of testosterone have not been shown to increase the likelihood of getting cancer in the first place. In fact, this story is a lot more complex, so we'll circle back to it in just a moment.

2) Causing cancer as a result of liver toxicity, such as in the case of methylated compounds, such as 'orals'. This has been clinically documented to occur, but usually only after rather intense and prolonged use. However, the reasons why it happen is well understood: they are liver toxic, and will cause inflammation and other bad things. Keep doing it long enough, and your liver will turn into a cancer-riddled sponge cake: https://www.hindawi.com/journals/cripa/2012/195607/

Interestingly, in the case studies that I have looked at, they seem to spontaneously resolve after stopping the use of orals. I don't think we have enough data to say for certain either way here - but I would personally be much more cautious with orals, because your liver is pretty important to keep functioning well and cancer is not something I would mess around with.

3) Causing cancer as a result of some unknown, unproven process. Insert cardarine meme here. In cardarine's specific case, we don't know, but we seem to have enough broscience that it doesn't seem to be an auto-cancer button - there have been human trials and no cancer has been seen in humans. This has already been covered in detail here: https://www.reddit.com/r/PEDsR/comments/815ixw/cardarine_cancer/ and here: https://www.reddit.com/r/PEDsR/comments/akq6gc/cardarine_human_trials/ and especially here: https://www.reddit.com/r/PEDsR/comments/anwr43/cardarine_cancer_growth_through_increased_atp/

Granted, that doesn't necessarily mean that it won't take 20+ years for cancer to eventually crop up as a result. The same can be said for many substances - hello, research chemicals! However, I personally believe that SARMs are very safe in this regard, as the most commonly used ones - Ostarine, LGD, and RAD-140 - are all in clinical trials for cancer patients, either to treat wasting disease, or - even more interestingly - to directly treat the cancer itself, e.g. https://www.businesswire.com/news/home/20161208005320/en/GTx-Reports-Results-Ongoing-Enobosarm-Phase-2 and http://clincancerres.aacrjournals.org/content/23/24/7608

And before you ask, no, I don't think that means that you should blast SARMs yearround as a "cancer preventative".

So what's the risk? I just wanna get jacked!

Credit to /u/pedsaccountonreddit for sparking the discussion:

"One interesting note is that men in general have higher rates of cancer than women, even when you adjust for non-sex specific cancers (prostate, breast, etc). There's some kind of mechanism there and it may be androgens / estrogens, may be lifestyle or may be something else entirely. So compared to baseline men here may be little difference between AAS users and men but there could still be some small difference.

Given the low general rates of certain cancers and the small AAS population size in studies it's not surprising it wouldn't have been detected if it was there, even if it was statistically significant.

My personal opinion is that it's pretty unlikely it increases cancer risk much or we'd have noticed something"

I agree with his assessment in general. I can also shed a bit more light on the topic:

  1. Historically, men led slightly riskier lifestyles, in terms of obesity, alcohol consumption, smoking, and others that increase the risks of cancer.

  2. There's generally more emphasis on early detection in females with things like much more common cervical cancer screening and breast cancer awareness compared to males.

  3. Most interestingly, there's a set of gene mutations that are responsible for some increased cancer rates in men - https://blog.dana-farber.org/insight/2018/10/men-likely-women-develop-cancer-course-lives/

Another interesting anecdote that an oncologist related to me was that based on his experience, men were usually more reluctant to see a doctor when something felt off. I'm not sure how much I would put stock into this, but the logic does make some amount of sense - generally, men are usually more stoic. And hey, just the other day I was reading a post on /r/peds about a guy going "hey, this drug gives me intense chest pain" and how his brother told him to suck it up and keep taking it. And so he did.

Wait, what was that about androgens? I really like testosterone.

Circling back to an earlier point:

There's something fascinating about prostate cancer in general, as an extremely high percent of men are likely to have it in their lifetime (https://www.ncbi.nlm.nih.gov/pubmed/2479160) - it's just that they usually die from other causes before it can kill them. Whether that's triggered by androgens is another matter - and, even more interestingly, there is mounting evidence that it may even be protective:

"After adjusting for previous biopsy findings as an indicator of diagnostic activity, TRT remained significantly associated with more favorable-risk prostate cancer and lower risk of aggressive prostate cancer.

Conclusion

The early increase in favorable-risk prostate cancer among patients who received TRT suggests a detection bias, whereas the decrease in risk of aggressive prostate cancer is a novel finding that warrants further investigation." - https://ascopubs.org/doi/full/10.1200/JCO.2016.69.5304

Adding to the increasingly likelyhiood of androgen safety, even in patients with existing or previous prostate cancer, is the recent work in the saturation model:

"A new paradigm gaining momentum to replace the traditional testosterone dependent theory has been termed the saturation model [14,21]. According to this model, testosterone and its intracellular metabolite 5α-DHT are critical for the growth of prostate tissue, but are in excess at physiologic concentrations. The theory maintains that serum testosterone concentration has limited ability to stimulate prostate growth. A hypothesized saturation point occurs at near-castrate levels where the low androgen concentration would be rate-limiting in prostate tissue proliferation [14]. The saturation model is supported by evidence derived from both animal and human studies. In rats, the half-maximal prostate growth occurs at approximately 36 ng/dL, which correlates to near-castrate levels of testosterone [22]. In human prostate tissue, the AR has been reported to become saturated at approximately 120 ng/dL in vitro, and 240 ng/dL in vivo [23,24]. A 6-month study of TRT in men with LOH revealed that despite administration of exogenous testosterone, which substantially increased serum testosterone, there was no increase in testosterone or DHT within the prostate itself [25]. This has led some to believe that a mechanism of the saturation model could be a lack of prostatic uptake of exogenous testosterone protecting the prostate from large serum androgens changes." -https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924951/

Also of note, from the same study:

"The Endogenous Hormones and Prostate Cancer Collaborative group analyzed existing worldwide epidemiological data representing over 95% of published data and found no associations between prostate cancer and prediagnostic serum levels of free testosterone, total testosterone, DHT, or any other endogenous sex hormones [26]."

This is opening up TRT to prostate cancer patients: https://www.renalandurologynews.com/home/conference-highlights/aua-2018-coverage/testosterone-therapy-safe-despite-prostate-cancer-history/

All of that said - these studies were on TRT doses, not supraphysiological doses of androgens or more exotic compounds commonly seen in bodybuilders. So, I think that caution is still very much wise in this area. But, it backs up my suspicions that in general, most PEDs/AAS do not increase the risk of spontaneously acquiring cancer.

Conclusion

In my mind, a responsible PED user is unlikely to have an elevated risk of cancer as a result of their use, but, I am not a doctor and we do not have hard, concrete data backing up that opinion. Be smart, stay safe. Get regular screening for cancers based upon your age and risk factors, live a healthy lifestyle, and educate yourself on the risks of anything you take.


r/PEDsR • • Jul 19 '19

Reducing Body Fat % Absent Caloric Deficit: Preliminary Thoughts NSFW

45 Upvotes

A recent conversation in a sourcing subreddit occurred in which it was suggested that AAS actively reduce fat absent of a caloric deficit, while SARMs do not. Of course, we all know of some compounds such as DNP, Clen and Cardarine, which will cause fat loss to occur, which are not AAS. Over the course of the discussion someone chimed in about Anavar (oxandrolone) directly reducing fat (again, absent a caloric deficit) which got me to doing some reading... how important is a caloric deficit for different compounds?

So first up, Testosterone most definitely improves body composition. I'm not going to spend much time on proving that out, but if you're interested in this as background reading check out this study. This is also established for Nandrolone and to less of an extent RAD-140 and MK2866.

My approach to cutting has always been diet based. When I was/am on PEDs, I would of course run something to help preserve muscle (often YK11 or Ostarine etc.) in addition to whatever dose of test I was choose/chose. My assumption is that the primary reason for using PEDs while cutting would be mostly for nitrogen retention benefit (to preserve muscle), and that the body composition benefits would be more or less negligible.

As it turns out, there is a significant impact to fat loss that can be attributed to PED use, depending on the compound being used.

Studies

Study 1: n=30 aged 40-60. After 3 months, both Anavar and Testosterone groups had lost 3% of body fat, with Anavar group losing a significant amount of visceral fat compared to placebo or the group taking Testosterone. This was also evidenced in subjects taking nandrolone decaoate (group subbed in nandrolone after elevated liver values on 'var risked the study). The group taking Test had a reduction in subq fat, but visceral fat increased slightly by 15cm2, while the group taking nandrolone had visceral fat substantially increase twice as much, to 30cm2.

Subq fat is found directly under skin, usually above muscle such as over top of your abs. Despite looking ugly, it's not as bad as you may think it to be. Visceral fat is fat that surrounds organs, and is almost wholly a bad thing.

Study 2: 344 rats. Testosterone reduced fat mass by 27%, while tren reduced fat by up to 51% (this fat loss was highly dose dependent), when compared to the group that had their testicles removed.

Study 3: n=120 elderly men using 3mg Ostarine. Fat mass fell by about 1.5%, while lean body mass increased by about 3%.

Study 4: n=18 men took 10mg/d Anavar for a week. After 7 days, baseline and post study hepatic ketogenesis was compared. It was established that 'var increases ketogenesis.

Nutrient Partitioning & Nitrogen Balance

So at this point in my research, I understood that fat loss is probably true of many/most AAS and PEDs with a high anabolic rating. But why? The most obvious reasons are nutrient partitioning and Nitrogen Balance.

Nutrient partitioning is the theory is that your body becomes more efficient in using the food it takes in. This is a big topic in itself filled with broscience and misunderstanding, but let's just take it for a given and we'll come back to this in a future write-up. Nitrogen balance has been covered a whole bunch already, but suffice to say that many PEDs improve nitrogen balance and it's a key part of building and maintaining muscle. More on this subject here. Nitrogen balance also supports improved protein synthesis.

This is all great for the gaining of muscle, but the gap in these three items is that it does not easily explain fat loss.

Stem Cells

Credit to /u/mike_hunt_hurts for this great article which offers a unifying theory on the improvements to body composition.

Testosterone promotes the commitment of pluripotent stem cells into the myogenic lineage and inhibits their differentiation into the adipogenic lineage. The hypothesis that the primary site of androgen action is the pluripotent stem cell provides a unifying explanation for the observed reciprocal effects of testosterone on muscle and fat mass.

Translated: stem cells turn into muscle cells instead of fat cells when subject is dosing Testosterone. Visual.

Presumably, as the body regenerates cells, this action will improve body composition over time. It would also be dose dependent - higher doses of Testosterone would result in a higher proportion of stem cells acting this way, and anecdotal evidence supports this view.

It's unclear if this would be true for non-testosterone based anabolic PEDs (specifically SARMs). I would lean toward that it's the activation of the androgen receptor that would trigger this given evidence of fat loss on RAD-140 and Ostarine, though the researchers hypothesize that it's specific only to Test. Ultimately they conclude it's an unknown.

Lipolysis / Ketogenesis

A old (1935) study done on castrated dogs shows that 'male hormone' (presumably testosterone) caused an increase in 'fat metabolism' (presumably lipolysis). The data is definitely hard to read, but the old-timey hand drawn graphs are cool. The break down of fatty acid they show is not completely unexpected. Study 4 shows the ketogenic effects that Anavar causes which also neatly helps explain the fat loss in Study 1, (though that specific Metho of Action may be limited to 'var and a few other compounds). This would be compound and dose dependent.

So What?

Assembling a complete list of compounds that have a proven impact on fat loss, and by how much, would be a worthwhile but enormously time consuming task... That said, I think it's fair to say that many/most commonly taken AAS and SARMs improve body composition through one or all of the actions above. SARMs are the least understood - it's entirely possible that the body composition benefits shown in Ostarine and RAD-140 trials are due to an as of yet unknown reason, though I lean toward what is outlined in the Stem Cell section.

I do wonder if their is an association between the anabolic rating and fat loss. Compounds that build comparatively more muscle would, under the Stem Cell theory outlined above, mean less cells are created as adipose tissue.


r/PEDsR • • Jul 11 '20

Old PEDsR DB Found! Merged w/ New Version NSFW

44 Upvotes

Hey everyone,

Last night I received an old version of the DB /u/BananaMuscle. Thankfully, he downloaded it out of concern that it might not be around forever.

I've merged the old DB with the new. Available at www.pedsr.com. I've also added a downloadable CSV file: https://docs.google.com/spreadsheets/d/e/2PACX-1vQr_GTq3uGV-Zr1Yl11Ku3DMC-5pyZEeTa9xNnGqoHSZlVHwWn_ucdMpVGAfZvnOdZscRRILkduNvd3/pub?output=csv.

The DB needs a lot of work still, but the major compounds are all there. Missing data for some of the less common supplements, vitamins and drugs.

All hail /u/BananaMuscle


r/PEDsR • • Mar 27 '20

Clenbuterol's safety and efficacy in various human studies NSFW

43 Upvotes

I've been doing a decent amount of research on clenbuterol as I find it interesting. After looking at a few studies on the various myotoxic effects of clen in in vivo rat models, I dug around quite a bit to see how this would transfer to human use. One of the studies on rats (Burniston et al. 2003) noted something which is worth keeping in mind when looking at human studies:

The present investigation has provided important information on the effects of acutely administered clenbuterol in the rat. In humans, a single dose of clenbuterol is generally self-administered as a 20-μg tablet. This is equivalent to 0.3 μg/kg body wt in a 70-kg male and is comparable to the dose administered in the only clenbuterol investigation using human subjects (23). To compare this with our 300-g rats, the dose needs to be scaled for differences in body weight and metabolic rate between the two species (Kleiber’s Law, 0.75 exponent). The relative dose per kilogram in the rat is 60 times that of the human dose, i.e., 17.9 μg clenbuterol/kg body wt. As demonstrated in Fig. 2, this dose is sufficient to induce 3.8 0.49% necrosis in the fibers of the soleus. Such a level of necrosis may appear small, but this is in response to a single administration, and this level of necrosis may underestimate the level induced by enteral administration (Fig. 5B). Individuals abusing clenbuterol often take several tablets and use the side effects of muscle tremors and tachycardia to judge their maximum dose. By using the above calculations, a daily dose of five to six tablets would be sufficient to reach the threshold (100 μg/kg body wt) for inducing damage in the heart and to induce 6.8 1.9% necrosis in the soleus. An important additional factor to be considered is clenbuterol’s long half-life within the body (38). Abusers of this substance often administer it by using an “on-off” cycle over several days. An accumulation of non-metabolized clenbuterol during the on stage of the cycle may lead to chronically elevated plasma levels, which would further impact myocyte loss in both striated muscles. Although the present investigation has not investigated the compound effects of chronic clenbuterol administration, it does demonstrate that, at the very least, damage will be induced at the onset of each cycle of administration.

So the dosage of clen shown to be myotoxic in rats may be of some concern for human use. Yet looking at the human literature, it seems that such concerns were not as severe. I'll try to keep my review here fairly novel, referencing studies mainly not mentioned in the the previous thread. I will also try to keep quotations down to what I feel is relevant. They are as follows:

Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.

Seven subjects with heart failure (5 ischemic, 2 non-ischemic) were started on oral clenbuterol 5 to 46 weeks post-LVAD implantation and up-titrated to daily doses of 720 μg.

No serious side effects or arrhythmias were seen in any of the subjects. Mild tremors were reported in 3 subjects. Mild muscle cramps in 4 subjects were noted at varying timepoints. CPK levels rose in all subjects after clenbuterol up-titration (peak range 133 to 1,497, median 314 mg/dl) and was elevated above normal in 4 subjects (Figure 4). There was only one significant elevation of CPK (1,497 mg/dl), measured in 1 patient after exercise, which normalized on subsequent testing. No subject required a reduction in clenbuterol dose due to tremors, muscle cramps or elevated CPK.

Clenbuterol Increases Lean Muscle Mass but Not Endurance in Patients With Chronic Heart Failure

Maximal strength increased significantly with both clenbuterol (27%) and placebo (14%); however, endurance and exercise duration decreased after clenbuterol. Prior data support combining exercise training with clenbuterol to maximize performance, and on-going studies will evaluate this approach...

After obtaining informed consent, subjects were randomly assigned to receive clenbuterol (n 10) or placebo (n 9). Patients taking carvedilol were switched to a selective 1-antagonist (sustained release metoprolol) before randomization. The dose of metoprolol was uptitrated to maintain heart rate within 20% of baseline during the study. Patients were given oral clenbuterol or placebo for a total of 12 weeks in addition to their standard CHF therapy. Clenbuterol was initiated at a dose of 20 g twice daily and uptitrated to 40 g twice daily after 7 days. This dose, used in the treatment of asthma, has been shown to improve performance in athletes and after orthopedic procedures...

Echocardiography. Clenbuterol had no effect on LVEF, diameters, wall thickness, or mass during the course of this study in either group.

Clenbuterol at 80 μg/day was well tolerated. Two clenbuterol subjects required discontinuation of study drug (asymptomatic slow ventricular tachycardia, severe muscle cramps without significant elevation in creatine kinase [CK]). One further clenbuterol subject had a high rate of ventricular ectopy that disappeared without reduction in the clenbuterol dose. One placebo subject had frequent non-sustained ventricular tachycardia. There were no implantable cardioverter-defibrillator discharges during the course of the study. Six clenbuterol and 2 placebo subjects reported mild muscle cramps. The CK value was elevated in 5 clenbuterol and 4 placebo subjects. The range of peak CK was 300 to 597 mg/dl in clenbuterol subjects and 305 to 408 mg/dl with placebo. Three clenbuterol subjects had cramps without elevation of CK, and CK was elevated in 1 clenbuterol subject who was asymptomatic. Of importance was that the CK level decreased despite continued drug administration (Figure 1B). Tremors were reported in 5 clenbuterol and 2 placebo subjects.

Clenbuterol, a β-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopaedic Patients

A double-blind, completely randomized, placebo-controlled study was carried out on 20 healthy male patients. Muscle strength and cross-sectional area were determined before and after surgery. Patients were treated with drug or placebo for 4 weeks postoperatively and there was a 2 week washout period.

The results suggest that, in the operated leg, clenbuterol treatment is associated with a more rapid rehabilitation of strength in knee extensor muscles; in the unoperated leg, knee extensor strength increased above the initial values after 6 weeks (P=0.01). However, in terms of absolute strength the differences were not significant between the two groups.

Treatment with drug or placebo began 12 h post-operatively; for the drug group, treatment comprised 20μg of clenbuterol twice daily for 4 weeks, followed by a 2 week washout period; the same regimen was used for the group taking the placebo, which comprised standard tablet excipients...

No patient in either group reported any side effects to the drug regimen used.

Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy

A double-blind, placebo-controlled, parallel, and randomized trial was employed. 71 patients, suffering from brachial plexus injuries, were given either clenbuterol (60 μg, bid) or placebo for 3 months. Before and at the end of the study, patients were given physical examinations, biopsies of biceps brachii, electromyograms (EMGs), and other laboratory tests...

Compared with placebo treatment, clenbuterol significantly mitigated the decreases in cross-sectional areas of type I and II muscle fibers and alleviated the reduction in fibrillation potential amplitudes, without any adverse effects. Conclusions. Clenbuterol safely ameliorated denervated muscle atrophy in this cohort; thus larger clinical studies are encouraged for this or other β 2 agonists on denervation-induced muscle atrophy...

This is the first clinical study showing that clenbuterol at 120 μg/day attenuated denervation-induced muscle atrophy in humans. It is reported that clenbuterol, at incremental doses from 120 to 720 μg/day over 12 weeks, increases the mass and strength of the healthy skeletal muscles in man [13, 14]. Animal studies show that denervated skeletal muscles are 20 times more sensitive to clenbuterol than healthy muscles and the heart [25]. Therefore, 120 μg/day of clenbuterol is believed to be a reasonably high dosage for the denervated muscles of patients. In the present study, the changes of fiber sizes and fibrillation potentials were used to evaluate the efficacy, aiding the avoidance of confounding factors resulting from variations in basal levels between individuals. Hence, it seems that fewer patients were required to reach a conclusion than the number needed by a study limited to just comparing endpoints.

Physiological dose of clenbuterol in rats, 10 μg/kg/day, attenuated denervated muscle atrophy without affecting the heart or causing myocyte death [25, 34]. That dosage was calculated based on the metabolic body weight that 10 μg/kg/day in rats is equivalent to 1 μg/kg/day in humans, a dose safely used in asthma treatments [25, 35]. The dose in the current study was 120 μg/day (~2 μg/kg/day for a 60 kg person). It was well tolerated and not associated with any obvious discomfort, except for one patient with transient nervousness. The newly occurring sinus bradycardia after the clenbuterol trial seemed not be relevant to the activation of the β1/2 agonist, which usually leads to tachycardia. Moreover, clenbuterol at the present dose did not exacerbate preexisting minor EKG abnormalities. This is consistent with previous reports that the effects of clenbuterol on the heart are observable at a dose of up to 2100 μg/day in combination therapy for patients using left ventricular assist device. Even at those doses, no severe adverse effects were encountered but tremors and muscle cramps [12, 13]. In our study, no adverse effects on liver, kidneys, lungs or hematopoietic system were observed after the 3-month intake of clenbuterol.

Beta2‐adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men

Herein, we examined the effect of clenbuterol ingestion on metabolic rate as well as skeletal muscle mammalian target of rapamycin (mTOR) phosphorylation and protein kinase A (PKA)‐signaling in six young men. Before and 140 min after ingestion of 80 μg clenbuterol, resting metabolic rate and contractile function of the quadriceps muscle were measured, and blood samples as well as vastus lateralis muscle biopsies were collected. Clenbuterol increased resting energy expenditure by 21% (P < 0.001), and fat oxidation by 39% (P = 0.006), whereas carbohydrate oxidation was unchanged. Phosphorylation of mTORSer2448 and PKA substrates increased by 121% (P = 0.004) and 35% (P = 0.006), respectively, with clenbuterol. Maximal voluntary contraction torque decreased by 4% (P = 0.026) and the half‐relaxation time shortened by 9% (P = 0.046), while voluntary activation, time to peak twitch, and peak twitch torque did not change significantly with clenbuterol. Glycogen content of the vastus lateralis muscle did not change with clenbuterol. Clenbuterol increased circulating levels of glucose (+30%; P < 0.001), lactate (+90%; P = 0.004), insulin (+130%; P = 0.009), and fatty acids (+180%; P = 0.001). Collectively, these findings indicate that clenbuterol is an efficient thermogenic substance that possibly also exerts muscle hypertrophic actions in humans. For these reasons, the restrictions imposed against clenbuterol in competitive sports seem warranted...

However, inclusion of a placebo-group would have strengthened the study design. For example, a confounding effect of fasting on plasma parameters could have been excluded. Nevertheless, it seems unlikely that such marked differences in circulating insulin, fatty acids and glucose should occur within the short span of the experimental day (~3 h). In fact, the opposite response of what we observed in the present study would be expected from glucose and insulin concentrations in response to fasting

Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease

This 52-week, phase I/II double-blind, randomized, placebo-controlled study investigated the novel use of clenbuterol in late-onset Pompe disease (LOPD) stably treated with ERT. Eleven of thirteen participants completed the study. No serious adverse events were related to clenbuterol, and transient minor adverse events included mild elevations of creatine kinase, muscle spasms, and tremors. At week 52, the 6-min walk test distance increased by a mean of 16 m (p = 0.08), or a mean of 3% of predicted performance (p = 0.03), and the maximum inspiratory pressure increased 8% (p = 0.003) for the clenbuterol group. The quick motor function test score improved by a mean of seven points (p = 0.007); and the gait, stairs, gower, chair test improved by a mean of two points (p = 0.004). Clenbuterol decreased glycogen content in the vastus lateralis by 50% at week 52. Transcriptome analysis revealed more normal muscle gene expression for 38 of 44 genes related to Pompe disease following clenbuterol. The placebo group demonstrated no significant changes over the course of the study. This study provides initial evidence for safety and efficacy of adjunctive clenbuterol in patients with LOPD...

The underlying mechanism for clenbuterol’s effects on muscle was demonstrated as increased expression of insulin-like growth factor (Igf) 1 and 2 and their receptors, including the Igf-2 receptor that is actually CI-MPR.7 Increased Igf-1 expression was also associated with the muscle hypertrophy following clenbuterol administration, which could be beneficial in Pompe disease...

A transient increase in CK and other mild AEs were the only side effects in the clenbuterol group.

We observed transiently elevated CK at week 18, which returned to baseline values by week 52...

The primary endpoint was safety of clenbuterol at up to 80 mcg twice daily, including avoidance of the following stopping rules...

Pilot trial of clenbuterol in spinal and bulbar muscular atrophy

Twenty patients with a diagnosis of SBMA were given oral clenbuterol (0.04 mg/d) for 12 months. The primary efficacy end point was the change from baseline of the walking distance covered in 6 minutes at 12 months. Secondary end points included the change over time in muscle strength assessed with the Medical Research Council scale, the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), and forced vital capacity values. Safety was assessed by a series of laboratory and instrumental tests, as well as reporting of adverse events.

Sixteen patients completed the study. There was a significant and sustained increase in walking distance covered in 6 minutes and forced vital capacity between the baseline and the 12-month assessments (p < 0.001). No differences were recorded in Medical Research Council or ALSFRS-R scores between baseline and follow-up assessments. Serious side effects, including those on heart function, were absent. A significant increase in serum creatine kinase levels was observed.

Myocardial Insulin-Like Growth Factor-I Gene Expression During Recovery From Heart Failure After Combined Left Ventricular Assist Device and Clenbuterol Therapy

Myocardial mRNA levels were determined by real-time quantitative polymerase chain reaction in 12 recovery patients (at LVAD implantation, explantation, and 1 year after explantation). IGF-I mRNA was elevated at the time of LVAD explantation relative to donors, with 2 groups distinguishable: Those with low IGF-I mRNA at implantation who showed significant increase during recovery and those with high IGF-I mRNA at implantation who remained high. Levels returned to normal by 1 year after explantation. Microarray analysis of implantation and explantation samples of recovery patients further revealed elevated IGF-II and IGF binding proteins IGFBP4 and IGFBP6. IGF-I levels correlated with stromal cell-derived factor mRNA measured both in LVAD patients and in a wider cohort of heart failure patients.

The mechanisms leading to elevated IGF-I expression in these patients remain unknown. However, we recently demonstrated that clenbuterol, an integral part of the Harefield bridge to recovery protocol, can induce IGF-I gene expression in cultured cardiomyocytes in vitro9 and may therefore contribute to inducing IGF-I in vivo.

The action of clenbuterol on sleep and symptomatology in depressives.

Five female inpatients with major depression (melancholic type, DMS-III-R) were treated with the beta-adrenergic agonist clenbuterol for three weeks, with doses ranging from 100 micrograms to 150 micrograms.

All patients complained of side effects, especially tremor, agitation and restlessness. The sleep EEG showed no consistent effects on sleep parameters, including REM latency and percentage of REM sleep...

The patients initially received 50 J.Lg clenbuterol per day. According to degree of compatibility and side effects, the dose was then increased in individually adapted steps. From the 14th day of medication on, the individual maximum dosage was given (150 μg in cases 1, 4, 5; 100 μg in cases 2,3).

In general, sleep was not affected by clenbuterol, except for extreme insomnia during the first night of REM latency medication in one case.

Clenbuterol (‘Spiropent’): a long-acting bronchodilator

Clenbuterol was compared to an aminophylline preparation in a double-blind crossover trial involving 47 patients with asthma and reversible airways obstruction. Following a 2-week control period, each drug was given for a 4 week period. The patients made daily records of the severity of symptoms and recorded PEFR morning and night. Both drugs produced a highly significant reduction in severity and duration of wheeze by day during the first 4 weeks, but only clenbuterol produced further significant reduction in these symptoms during the second 4 weeks.

The incidence of side-effects with both active drugs was fairly high, but the majority of side-effects, in fact, were mild or moderate...

Spiropent (clenbuterol): another choice for patients with chronic reversible airways obstruction.

Oral administration of spiropent (clenbuterol), 20 mcg on waking in the morning and 40 mcg before sleep, daily for 2 months, was studied in 34 patients, 19 males and 15 females, aged between 27 to 73 years (mean 47.8 +/- 17.5), who had chronic reversible airways obstruction as defined by the A.T.S.'s criteria...

Except 5 patients, 2 suffering from severe headache and 3 from poor control of asthma who had withdrawn from this study after one week of treatment, all patients completed the trial. Six out of 29 patients who completed the trial needed additional steroid treatment and 9 needed beta 2-agonist inhalation during the treatment period. The results showed improvement of FEV1 more than 15% in 21 patients (72%), FVC in 17 patients (59%) and PEFR in 20 patients (69%). These increases were significant (p less than 0.0001). However, only 12 patients (41%) had marked subjective improvement at the end of treatment. Cough (21%), headache (10%), nausea (7%) and dizziness (3%) were the commonest side-effects. No clinical or statistical difference was found in changes of vital signs and laboratory parameters. In conclusion, clenbuterol was effective and well-tolerated in the majority of patients enrolled in this study with minimal side-effects and good compliance. It may be used for long-term treatment of chronic reversible airways obstruction at lower cost.

A pilot trial with clenbuterol in amyotrophic lateral sclerosis

Sixteen patients, 12 males and 4 females, mean age 55.4 years (range 25–76 years), affected with clinically definite or probable ALS according to El Escorial criteria (11) with documented progression of disease, aged less than 80 years and with forced vital capacity (FVC) >50% of the predicted value, gave written informed consent to participate to this study...

All patients were on riluzole at the standard dosage of 100 mg/day and were not asked to discontinue the drug for ethical reasons. Patients were treated orally with 20 micrograms of clenbuterol three times a day (total 0.06 mg/ day) for six months. A dose titration at the beginning of the therapy was used to minimize side-effects...

The mean composite myometer score significantly improved from baseline by 20% at three months (p=0.01) and by 23% at six months (p=0.01) for the upper limbs; and by 22% at three months (p=0.0002) and by 27% at six months (p=0.0002) for the lower limbs (Table I). Although the mean composite MRC score of the upper and lower limbs also improved, these changes did not reach statistical significance. No change was observed in the ALS Functional Rating scale at three and six months...

Clenbuterol safety assessments included clinical examination, cardiac evaluation, electrocardiogram and blood electrolytes every three months. The drug was generally well tolerated in association with riluzole and side-effects were never dose limiting or required discontinuation. Side-effects always occurred early in treatment (within the first few days) and resolved with continued use. The main complaints were hand tremors (two patients), cramps, fasciculations (three patients) and nervousness (three patients). In none of the patients was heart rate increase recorded or palpitations reported. No blood electrolyte abnormalities were observed.

Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies

We report the outcome of trial of clenbuterol in four adult muscular dystrophy patients. One patient with Becker type, one with Miyoshi type, and two with facioscapulohumeral type were given clenbuterol (30 or 40 micrograms/day) for 6 to 18 months. We evaluated muscle strength of isometric contraction, grip and pinch power, compound muscle action potentials of intrinsic muscles, vital capacity, urinary creatinine excretion, and muscle CT. Power and volume of well preserved muscles increased mostly, while those of atrophic muscles did not improve. Vital capacity increased in two patients. No improvement of ADL was observed presumably because ADL was mainly determined by the most atrophic and weak muscles. Irrespective of type of muscular dystrophy, administration of clenbuterol may be beneficial in early stage of the disease.

(Note that this is published in an obscure Japanese journal. I can't sci-hub it, so I can't examine what effects clen may have had on biomarkers.

Effect of Clenbuterol using as weight loss on liver enzymes and lipids profile

The current study is considered at the effect of 3 month using Clenbuterol for weight loss in 22 healthy men comparing them with 30 healthy men who do not take Clenbuterol...

hey used it in cycle form, meaning not using in stable doses, that they began with 20 mcg dose and raised the dose to 140 mcg and then returned to 20 mcg. Table 2 illustrated the cycle of use...

The study showed a statistically significant decrease in weight (90.78 ±9.38) and BMI (27.66 ±3.51) in T NO Clen. group and in T+Clen group, their weight being 88.0 ±13.58 Kg and their BMI were 26.94 ± 4.15 for those who showed more lose in their weight and BMI when compared with the other groups as shown in Table 3. For the subjects in control group, they showed losing in their weight (95.42 ±10.24) and lowering their BMI (28.65 ± 2.62) but these results were not statistically significant. For enzymes level (AST, ALT and lipase), in spite of increasing their levels in T NO Clen and T+Clen groups when compared with control groups, all enzymes levels were increased in T+Clen group more than in T NO Clen group. Whereas ALP enzyme was increased only in T+Clen group. Table 4 demonstrated these differences in levels.In Table 5, TC, TG, and LDL levels were lower in T NO Clen group (133.24 ±7.65, 88.01 ± 6.63, 73.62 ±7 .91), respec-tively when compared with the other groups after the period of study. But in T+Clen group, TG level were more high (130.43 ±8.01) when compared with the other groups. At the other side, HDL level were increased in T NO Clen group more than in T+Clen group when compared with the control group.

The clen group's liver enzymes and lipase levels here were as follows:

AST = 45.43 (IU/L)

ALT = 56.46 (IU/L)

ALP = 42.76 (U/L)

Lipase = 60.13 (U/L)

So a bit elevated, but not the worst.

 

That's about all of the literature that I could find for the time. I may add some more later if I can dig some more up. Overall, clen seems to be fairly safe and well-tolerated in human trials.

I would kindly suggest to anyone planning on using clen to just start out with a conservative dosage. Begin with just 20 μg's a day and slowly increment after a couple of weeks. There's no need to go to crazy because the side-effects after a certain threshold won't be worth it.

If anyone is aware of any other human studies that I missed; then please let me know.


r/PEDsR • • Jan 03 '20

Boron - Multi-Purpose Supplement, Beneficial for Men & Women NSFW

43 Upvotes

Boron is a trace mineral, with many roles in the body. It's proven to play a role in several biological processes:

An impressive list!

It's found in fruits and vegetables (apples, coffee, beans, milk, potatoes), with the average person consuming around 2mg of it in their daily diet.

Everything old is new again

Comic, wtf bro - this is old news. My <insert older relative> used this back in the 80s & 90s.

Boron used to be a staple supplement in the 80s, definitely before my time in the gym, though admittedly not by that much. Over time it's lost its appeal, or at least I don't see it being mentioned all that much, for reasons I'm not too sure about though I suspect it's marketing related: folks continue to look for the holy grail of testosterone boosters - that which significantly elevates testosterone to supraphysiological levels, and is a 'natural' supplement. Boron won't do this - nothing natural likely ever will - and so supplement manufacturers and marketers move on to mislead customers with 'new and improved' compounds.

Dose Dependent Results

6 healthy males aged 18-29 were given 11.6mg daily. Just 6 hours post dose, subjects showed significantly lowered SHBG. Following continued use by the end of the week free test was up 30% (from 11.83pg/ml to 15.18pg/ml), and e2 was down (42.33pg/ml to 25.81pg/ml). Lutenizing hormone also slightly rose, as did total test.

Similar results were found at 6mg/d

The ability to influence testosterone in men is highly dose dependent however: a third study in men used 2.5mg over 9 weeks, but showed no statistically significant differences in hormones. This is likely due to a similar amount of boron being available in an average persons diet, and such a (relatively) small increase in a trace mineral just ain't gonna have the same effect.

In women, Boron also appears attractive from a hormonal context: 13 post menopausal women aged 48-82 took 3.5mg/d and significantly increased both estradiol (11.9-26.9pg/ml to 35.9-37.5pg/ml) and testosterone (0.30-0.60ng/ml to 64-0.71ng/ml)

Minimum effective dose is about 3mg in adult women, and probably around 6mg in adult men. Toxicity is low, and the Tolerable Upper Limit is at 20mg for an adult. For both men and women, I don't see a reason to not use up to 10mg per day if they do choose to supplement.

So What?

Given Borons postivie impact to hormones and lowering of SHBG I do see multiple potential roles for the compound regardless of sex. The biggest ones that jump out at me are:

  1. Natural athletes will benefit from the high free androgens circulating, courtesy of the lower SHBG

  2. Athletes on cycle will similarly benefit from lower SHBG

  3. Athletes post cycle will benefit from increases in LH

  4. Everyone benefits from the improved vitamin D and magnesium absorption

Expectations for this compound should be tempered and not over-hyped - this is not comparable in any way to a steroid injection. All the same, it does have a benefit.


r/PEDsR • • Nov 28 '18

Nebivolol – the ultimate antihypertensive drug that all users should consider NSFW

43 Upvotes

Background

As we know, anabolic hormones alter the renin-angiotensin-aldosterone system causing potential changes in salt balance, water retention, blood volume, then subsequently hypertension, LVH and kidney damage. Aside from this mechanism, anabolic hormones also appear to increase noradrenergic response due to their androgenic signalling. 

Coupled with changes in LDL and HDL ratio, not really a pleasant environment for your heart, arteries, circulation.

  1. Standard (non selective) beta blockers causes major alterations in insulin sensitivity and lipid mobilisation. Resulting in type 2 diabetes, and therefore fatloss becoming exceedingly diminished.

  2. Angiotensin II receptor antagonist and ACE inhibitors lower plasma noradrenaline levels. Not exactly a good thing when you need this to increase for optimal CNS engagement (strength), fat loss, and energy. 

I’ve looked in to all these other classes of drugs used to treat hypertension (except diuretics), and they all have side effects that are not exactly ideal. Generally, they don’t target the core issue, in relation to hormone use, this being alterations in the system I mentioned above. Instead they increase Renin and Aldosterone as a compensatory mechanism whilst masking/overriding their effects.

Here comes Nebivolol. A cardioselective beta 1 antagonist. It is also a beta 3 agonist. Amazing. It has profound nitric oxide properties as well. It doesn’t alter exercise tolerance, it actually aids in fat loss, it doesn’t alter plasma noradrenaline levels (it just blocks noradrenaline from acting on the beta 1 receptors in the heart and kidneys); Lowers renin and aldosterone; It reverses LVH; increases glucose and lipid metabolism; increases total Testosterone by 80-90%; and many more including reduction in ED… literally void of any side effects (aside from hypotension and minor other things - all dose dependant). 

Studies

“In the nebivolol group, a significant decrease in blood pressures (P < 0.001) and heart rate (P < 0.01) was seen. Nebivolol therapy also suppressed plasma renin and aldosterone concentration (P < 0.02) but increased plasma atrial natriuretic peptide levels (P < 0.03)”

http://www.sciencedirect.com/science/article/pii/016752739290238X

Angiotensin II receptor antagonist increase Renin and Aldosterone, whilst Nebivolol decreases.

http://www.sciencedirect.com/science/article/pii/S193317111500618X

“Nebivolol is endowed with peripheral vasodilating properties mediated by the modulation of the endogenous production of nitric oxide. It does not significantly decrease airway conductance compared with atenolol and propranolol. Nebivolol does not compromise the left ventricular function, but it may increase stroke volume, and does not reduce heart inotropism during exertion”

http://www.sciencedirect.com/science/article/pii/S1043661898903875

“Nebivolol, through β3AR, is able to induce lipolysis and promote thermogenic and mitochondrial genes. The induction of lipolysis and the thermogenic program could explain the reduction of lipid droplets size”

http://journals.lww.com/jhypertension/Abstract/2014/02000/Nebivolol_induces,_via__3_adrenergic_receptor,.25.aspx

“nebivolol does not alter exercise capacity significantly in healthy volunteers.”

https://link.springer.com/article/10.1007/BF00051145

“Our findings in these short-term trials confirm previous reports regarding the neutral effects of nebivolol on lipid profile and carbohydrate metabolism.21,22 Recent data suggest that compared with metoprolol, nebivolol at a comparable dose improved oxidative stress and insulin sensitivity, decreased plasma soluble P-selectin, and increased adiponectin levels in hypertensive patients.”

http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2009.00119.x/full

“Free fatty acid, free glycerol, plasma catecholamines, beta-endorphines and atrial natriuretic peptide (ANP) increased before and after treatment during maximal and submaximal exercise but remained unaltered by nebivolol treatment”

“nebivolol did not negatively affect lipid and carbohydrate metabolism and substrate flow.”

https://www.ncbi.nlm.nih.gov/pubmed/11607802

“Bisoprolol and nebivolol significantly increased concentration of testosterone (by 82 and 85%, respectively) and prolactin (by 77 and 83%, respectively), lowered levels of estradiol and follicle-stimulating hormone, improved vascular blood flow in penile arteries, and did not worsen sexual function.”

http://europepmc.org/abstract/med/18260876

“Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension”

http://circ.ahajournals.org/content/104/5/511.short

“Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells”

https://academic.oup.com/cardiovascres/article/49/2/430/400450

“Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993984/

“Results of the present study demonstrate an inhibitory effect of nebivolol on several components of the atherosclerotic plaque which contribute to its progression. As compared to the control mice, the nebivolol-treated animals showed, along with significantly lower plaque size, a decrease in necrotic core size, collagen content, macrophage and T cell density, and activity of matrix metalloproteinases. In contrast, the drug increased the content of smooth muscle cells in the fibrous cap of the plaque.”

http://jpp.krakow.pl/journal/archive/12_13/articles/08_article.html

“In hypertensive patients with LVH, nebiviolol, combined with thiazide diuretics, significantly decreased LVMI. Moreover, Nebivolol was able to modify LV geometry from concentric to eccentric. Such effects were significantly higher in patients treated with nebivolol 5 mg/daily than in patients treated with ramipril 2.5 mg/daily. The clinical implication of these results is that the\ treatment with nebivolol/thiazides in hypertensive patients reduces the cardiovascular risk associated with LVH”

“Both nebivolol and ramipril reduced left ventricular mass and left ventricular mass index, but the effect of nebivolol was significantly higher than ramipril. Nebivolol was also able to induce a statistically significant change in the left ventricular geometry evaluated by the relative wall thickness, a marker of cardiovascular risk. “

“Nebivolol reduces arterial stiffness and central blood pressure which have a pathogenetic role in promoting left ventricular hypertrophy”

http://www.europeanreview.org/wp/wp-content/uploads/1269.pdf

“Available data suggest that nebivolol has a protective effect on left ventricular function. The drug appears to reduce preload and maintain or decrease afterload. Total peripheral vascular resistance did not increase in any study of nebivolol. Heart rate and left ventricular end-diastolic pressure are decreased, whereas stroke volume is increased and cardiac output is generally maintained, notably in patients with heart failure. Nebivolol reduced left ventricular mass in hypertensive patients with left ventricular hypertrophy.”

https://link.springer.com/article/10.2165/00003495-199957040-00011

Usage

I personally use 1.25mg per day as a preventative measure in the background. However, dose can be increased depending on how high your blood pressure is.

Bioavailability is low at around ~10%. Sublingual administration have been shown to increase this by 7 fold.

Synergism

Works in synergy with diuretics as well as NO promoters like Citrulline and PDE5 inhibitors.

Note

Issues with water retention may not be resolved with any antihypertensives except diuretics. Where water retention is concerned, a thiazide-like diuretic like Chlortalidone (Chlorthalidone) can be used. Chlorthalidone also has novel mechanism that sets it apart from other diuretics. A write up will be done on Chlortalidone soon to illustrate how important this particular diuretic is to anabolic steroid users - it will literally reverse LVH and reduce left ventricular mass. Chlortalidone alone will normalise blood pressure to perfect levels for those who have hypertension due to water retention.


r/PEDsR • • Sep 30 '18

Post Cycle Strength Preservation NSFW

40 Upvotes

TL:DR expect to lose some size and strength once discontinuing PEDs. Eat well, often and get enough sleep.

Maintaining mass post-cycle can be hard. Maintaining strength can be even harder. The last thing you want to do is be right back where you started from pre-cycle. You put your liberty and your health at risk, and for what? A fleeting 8 weeks of looking your best?

You may not look as good off-cycle as you do on, but there some things we can share to help you preserve as much muscle as possible. The key is nitrogen balance.

Nitrogen Balance

Positive nitrogen balance is necessary to maintaining and building muscle: Positive nitrogen balance is associated with periods of growth, and tissue repair. This means that the intake of nitrogen into the body is greater than the loss of nitrogen from the body, so there is an increase in the total body pool of protein.

Negative nitrogen balance is associated with periods of fasting. This means that the amount of nitrogen excreted from the body is greater than the amount of nitrogen ingested.

Increase Protein

Protein is a good source of nitrogen: meat, dairy, eggs, nuts and legumes. When coming off-cycle, increase your protein intake to at least 0.82g/lb (if you’re not already exceeding this) and preferably more if you can manage it. This is an increase on the amount that is strictly necessary for muscle growth for most folk, but high protein meals have been shown to increase anabolism and may help body composition.

Don’t Cut Off-Cycle

In addition to protein, PEDs also increase nitrogen retention and that’s why, imo, you should cut on-cycle and not off. Lack of calories creates a negative nitrogen balance, and not only are you feeling flat from less energy, your body cannot maintain and repair muscle.

Eat at maintenance, or slightly above. The exception to avoiding weight loss would be where you have ran a compound known for ‘water weight’ - dbol comes to mind. Some weight loss off-cycle is inevitable for such compounds, and you will be losing weight post-cycle even eating at maintenance. In that case, you weight loss is OK, and weight will plateau after a week or so.

MK677

I personally went off-cycle for 8 weeks after an extensive period on-cycle. Following a recommendation from /u/MezDez and from what I knew from a write-up, I tried MK677 during this period. I still firmly believe we over-use this compound far too much, and dismiss it’s impact on blood sugar levels far too quickly, but after using it off-cycle I’m a believer, born again. On my last cycle, I had a 1RM of ~300lbs on bench, which admittedly wasn’t a focus at the time. However, after 8 weeks off-cycle using MK677, 2 weeks of which I was sick with the plague, my 1RM remained steady at 300lbs. Now back on cycle doing a simple bulk TRT + LGD4033 cycle, it’s back up to 320lbs at 4 weeks in.

MK677 reverses diet induced catabolism

Sleep

Your largest GH spikes during sleep. In men approximately 70% of the GH pulses during sleep coincide with short wave sleep, and the amount of GH secreted during these pulses correlates with the concurrent amount of SWS. Short Wave Sleep aka deep sleep. Basically, get good quality sleep.

GH is important because it improves nitrogen balance. This is why MK677 is so effective too.

Hormone Recovery

If you’re not on TRT, and you did a SARM only cycle, your natural T levels will recover in about 35 days post cycle where you may wish to get bloods to see where you’re at. If your cycle included AAS, engage in a PCT protocol. If you do not, low T states are associated with loss in muscle mass (duh).

As to diet, while high fat diets are linked to higher testosterone levels and lower fat gain, at the expense of cardiovascular health and increased risk of heart disease, I see no evidence at the time of writing that it will help your testosterone levels recover any faster.

Even with doing the right things, you WILL lose muscle post cycle...

There is the occasional exception, where folks seemingly continue to gain size and strength through PCT. In those instances, I suspect that those users must be a ways from their natty limit. But for the majority, you have less protein synthesis going on due to less nitrogen and now cortisol is no longer blocked from the androgen receptor as it was during on-cycle. This in itself decreases protein synthesis. (Cortisol is a whole subject in itself, and we’ll tackle it another time)

The good news is that your non-natty status has resulted in an increase in myonuclei / muscle fibre. Congrats, it’s permanent, probably. That means once your test levels have rebounded, you will recover some strength, and/or it will be easier to get back to your on-cycle 1RM’s and set brand new 1RM’s next cycle.


r/PEDsR • • Jan 28 '19

Cardarine Human Trials NSFW

39 Upvotes

Credit to /u/Enlilasko for humoring my repeated requests. He located three studies below where cardarine (GW501516) was given to humans, rather than rats. The studies themselves did not focus on cancer, at all, but on lipids and other markers.

> wtf, human cardarine studies? Why do people only talk about the rat studies?

Toxicity has been evaluated in long-term animal studies, showing an increase in tumour formation. These animal studies (usually performed in parallel with early clinical development) resulted in termination of the clinical development program. The increase in tumour development was not replicated in the early human studies, which used lower doses and shorter study duration, so long-term effects in humans are unknown.

Human Studies

To recap for our newer readers, or those new to PEDs, cardarine is a popular PPAR agonist that improves endurance and catabolizes fat. But, there are rumors around it causing cancer, based on two studies. More on that further on, or read about it in detail here.

Study 1, 2007: folks were given placebo (n=6), 2.5mg (n=9) or 10mg (n=9) once daily for 2 weeks while sedentary. No significant adverse effects were noted.

Study 2, 2011: similar in scope to the first study, with administration of 2.5mg once daily or placebo (n=13). No significant adverse effects were noted and no changes in liver, muscle enzymes, creatine or protein in urine that might demonstrate kidney damage. There were significant changes (positive) to triglycerides, HDL cholesterol.

Study 3, 2012: Actually two studies, with similar results. In the core study, folks were given placebo (n=78), 2.5mg (n=48), 5mg (n=83) or 10mg (n=59). Notably, 14% were women (female rats had a higher mortality rate in Cardarine studies), but there was no differences in trends between men and women. In the exploratory study of men only, 16 subjects given 5mg and then 10mg, with 21 given placebo.

In both, LDL and triglycerides were lowered significantly, and HDL was increased. All were dose dependent. The study notes that no plateau was achieved, meaning that improvements in these numbers may have continued beyond the 12 weeks. Both studies saw improvements in insulin sensitivity and decline in fatty acid ~20%.

Presumably, all of this came with body composition benefits, but body fat% was not captured. Body weight changes were not significant (the 10mg group gained a kg on average).

So What?

That some groups received 10mg for 12 weeks is also very promising for our purposes as this is the recommended starting dose in the PEDsR DB, though I typically shy away from long cardarine cycles personally. Cancer was found in a human equivalent dose of 43.2mg (200lb male) in rats, so the 10mg dose represents the closest dose we have.

In all of these human trials, there was no evidence included in the journal that indicated tumor growth, benign or otherwise... they weren’t looking for it. Or perhaps it was never there to begin with.

Finally, we still do not have data on long term effects of cardarine use on humans.


r/PEDsR • • Aug 24 '20

Case Report: HCG alone prevents suppression on SARMs NSFW

38 Upvotes

The anabolic potential of a SARM cycle is often limited by suppression of endogenous testosterone production. While the exact mechanism is unknown, studies have shown that SARMs such as LGD-4033 quickly and significantly lower endogenous testosterone production despite having minimal effect on LH/FSH. Low testosterone can lead to the classic symptoms of fatigue, low libido, erectile dysfunction. Anecdotally it can also reduce motivation to exercise and impair further progress on the user's fitness goals. Testicular discomfort is also a reported side effect of SARMs, likely due to testicular atrophy caused by HPT axis suppression. These negative effects seem to become bothersome at the six week mark for many users.

Previously documented methods to prevent suppression include testosterone replacement therapy (TRT) and concomitant SERM use. Each of these methods have downsides: for TRT, intramuscular (IM) injections may be distasteful for users, users may be hesitant to acquire controlled substances, and due to significant HPT axis suppression testicular atrophy can be worsened compared to SARM use alone. For SERMs, users can experience the standard side effects of fatigue, depression, impaired libido, and erectile dysfunction, which can be similar to the symptoms of T suppression that they are intended to prevent. Additionally SERMs can lower IGF-1 levels which can impede muscle hypertrophy.

To date, there has been no documentation of an attempt to prevent T suppression during SARM use with human chorionic gonadotropin (HCG) injections. HCG acts as an analogue to luteinizing hormone (LH), which stimulates testosterone production in the testes. HCG has been used with success as monotherapy to treat men with low testosterone. Ontologically, HCG may prevent suppression by providing a continued signal to the testes to produce testosterone, bypassing the endogenous HPT axis that is impaired, for whatever reason, by the presence of SARMs. Testicular atrophy, and possibly testicular discomfort, would be prevented by HCG administration, and may lead to more rapid return of normal HPT axis function upon the cessation of SARM use.

A healthy 35 year old male volunteered to test this effect. This subject had prior experience with SARM-only cycles and at that time experienced significant laboratory-confirmed testosterone suppression with reported symptoms such as fatigue, decreased mood, reduced work capacity, and testicular discomfort. For this test, the subject was given 6mg of LGD-4033 daily with 500U HCG administered twice weekly via subcutaneous injection. Laboratory tests were taken prior to therapy and at six weeks while on therapy.

NamePre-cycleAt 6 weeksReference
Testosterone (ng/dL)590385250-1100
Free T (ng/dL)101.2104.735-155
SHBG (nmol/L)461710-58
Estradiol (ng/dL)2626<29
LH (mIU/mL)1.8<0.21.5-9.3
FSH (mIU/mL)3.01.31.6-8.0
AST (U/L)222010-40
ALT (U/L)17198-40
Total chol. (mg/dL)153125<200
HDL (mg/dL)7542>40
LDL (mg/dL)6866n/a
Triglycerides (mg/dL)5461<150

As expected, LH and FSH were suppressed from the exogenous HCG. SHBG and HDL were significantly reduced, which is universally seen with SARMs and is a signal of the efficacy of the LGD-4033. Total testosterone was mostly maintained and free T levels were entirely maintained. No effect was seen on liver enzymes. In contrast with his SARM-only cycle, the test subjected reported no symptoms of testosterone suppression with maintained energy levels, libido, and sexual function. No symptoms of testicular discomfort were experienced.

Due to LH and FSH suppression, users will likely benefit from post-cycle therapy (PCT) upon cessation of SARM+HCG therapy. The ideal PCT regimen in this circumstance is unknown. Theoretically, with testicular function less suppressed compared to a SARM-only cycle, PCT of a shorter duration or lower dose may be equally effective.

In summary, HCG 1000U weekly is an effective tool to prevent testosterone suppression on SARM therapy. HCG is a good adjunct for users who are prone to T suppression and/or testicular discomfort on SARM-only cycles, who would prefer subcutaneous to IM injections with TRT, who would prefer not to handle controlled substances such as TRT, and who are susceptible to side effects from SERMs. By preventing T suppression, HCG may allow users to extend their SARM cycles beyond the standard 8-12 weeks as long as liver and lipid values permit.


r/PEDsR • • Nov 08 '19

Reversing Arterial Stiffening: Vitamin K NSFW

38 Upvotes

This write up came about from a conversation with /u/mike_hunt_hurts. For those that don't know Mike, he's a biochemist or somesuch. As a result, I bounce product ideas and PEDsR posts off of him, and is generally a pretty great in sharing his schooling with schmucks like me. He's not going to have the most impressive lifts on anyone on Reddit given his relative low doses of PEDs if he uses them at all, which he makes clear when he started explaining his approach:

I try to focus on risk/reward, (and) SARMs have a pretty good ratio, as does TRT + non aromatizing cycles... Vit K is almost mandatory when blasting for its atherosclerosis reducing effects.

This last part piqued my interest - the world of PEDs is too large to have a complete encyclopaedic knowledge of all compounds at all times, and for me Vitamin K was something I'd vaguely heard of but had not looked into. My own formulation, for example, includes coffee bean extract, garlic, hibiscus, and olive leaf - all wonderfully effective at reducing blood pressure and preventing cardiac damage... but reversing cardiac damage?

Koagulationsvitamin - Vitamin 'K'

Vitamin K plays a key role in helping the blood clot, preventing excessive bleeding. It's given to newborns: All babies are born with low levels of vitamin K, an important factor in helping a baby's blood clot. We give all healthy newborns a vitamin K shot shortly after delivery to prevent a type of bleeding called Vitamin K deficiency bleeding (VKDB), formally known as hemorrhagic disease of the newborn. This condition is/was common in about 1% of all new borns.

It's found in kale, spinach, turnip greens, collards, Swiss chard, mustard greens, parsley, romaine, and green leaf lettuce, as well as in relative low quantities in other products.

Vit K benefits us by modifying proteins so that they bind with calcium. Not only does this help blood clot, it indirectly helps strengthen bones and reduces arterial stiffness. The latter is our main interest here.

Taking Vitamin K for Heart Health

In short, Vitamin K seems to reverse the thickening / stiffening of arteries. This is a pretty big deal. Arterial stiffness is caused by a buildup of plaque, which are clumps of cholesterol, calcium, fibrous tissue and other cellular debris that gather at microscopic injury sites within the artery. This process is called atherosclerosis. And it can kill even the most shredded gym rat.

Trials are spotty, but promising. Here's two relevant ones.

1: 42 patients with kidney disease were given Vit K2 (MK-7... see below for detail on what this is) at a dose of 90ug/d, along side 10ug of Vitamin K+D. Compared to just the group receiving Vitamin D, the above group saw a slowing of thickening of the carotid artery. The group was one that is typically at risk, so a slowing, rather than a reversing, is still a huge win.

2: MK-7 was given at a dose of 180ug for three years. In healthy post-menopausaul women, aortic stiffness was improved in all women, and significantly so in those who had a high baseline stiffness. Here appears the evidence for the reversing arterial stiffness. And it's amazing.

Different forms of Vit K - K1, K2 and K3

  • K1 is very common in the western diet, but is poorly bioavailable resulting in less than 10% of it being absorbed.

  • K2 has many forms of the vitamin due to a slight difference in the molecular structure - it's not important to understand the exact difference in the molecule, but if you are Examine has a good write up on it - search for MK-n (where 'n' = a presumably infinite number of the kinds of this type of Vit K). K2 is probably better absorbed due to the fatty foods its present in - meat, eggs and dairy, but it exists only in small quantities. As a result, you will see MK-4, and MK-7, MK-8 and MK-9, with the bigger the number the longer the chain. As a rule, the bigger the number, the more fat soluble it is.

  • K3 is a synthetic form now only used in Animals as it can cause liver toxicity, jaundice and hemolytic anemia.

How Much?

K2 is perhaps the more beneficial between K1 & K2 when given in equal doses so I'm going to focus the following all for K2.

Firstly, a minimum of 120mcg/d for men and 90mcg/d for women is needed to allow your blood to clot.

Vit K1 & K2 are tolerated well in high doses. Allergic reactions are possible in injections, but there are no significant adverse effects recorded by oral administration. Doses of up to 45mg (45,000mcg) have been used as a loading phase.

Mike uses 600ug as the therapetutic dose, and 200ug as his maintenance dose. This seems reasonable based on Study 2 + minimum effective doses above. /u/Enlilasko, another very smart and knowledgeable science-y person, advised that it's often used the mg range without issue.

So What?

All in all, definitely something I'll be running alongside testosterone. Atherosclerosis, and subsequently stroking out and being a vegetable, is one of my deepest fears, and I've added Vitamin K2 MK-7 to my Amazon shopping cart... it's not exactly expensive either. $8 for a months supply.


r/PEDsR • • Aug 11 '20

Dose Calculator + Steroid Plot Hosted on FitDataMax NSFW

36 Upvotes

For the past 3 months, I've watched /u/Krato-FDM build what I'm regarding as perhaps one of the most useful sites for degenerates such as ourselves called FitDataMax (FDM for short). His landing page offers some insight into the goals of FDM. His mission:

Serious athletes need a way to manage and optimize supplementation, training, and health data in one place. FitDataMax is a platform for empowering serious fitness users with data analytics tools to improve their health, exceed their fitness goals, and maximize efficiency.

FDM functions similarly to how MyFitnessPal operates in that you can log what you need. In this case, you can log supplementation, training, blood tests. Much of this is in beta - it works, I think, but what really interests me is the aggregation of all the useful shit that we need into one spot. Today, the following is live:

  • Krato has live a profile on most compounds (shoutout to those in the Discord who worked on that + Krato + anything taken from the PEDsR database)

  • Dose Calculator (public) - calculating the dose someone needs to take converting between mg to ml

  • Reconstitution Calculator (public) - calculating the amount of BAC to mix with compound and the subsequent dose to achieve the desired mg

  • And, Steroid Calc (private - sign up required) - useful for all of us who need to plot out our peaks and troughs.

There's some other stuff live, like a link to Xylia Testing who performs quantitative and qualitative testing of mystery powders.

Worth a look, and your support. In another 3 months or so, the site will have 100% functionality and be an integral part of how we track our use of compounds.

His intro is here, where he talks about himself and background, for anyone who is interested.


r/PEDsR • • Jan 25 '19

Stretching Increases IGF1, Protein Synthesis NSFW

36 Upvotes

Muscle growth in response to mechanical stimuli : a study looking at electrical stimulation, stretching and its effect on muscle growth. This was shared around the Discord channel, and it by itself is an interesting concept.

This was a 3 day experiment looking at muscle growth stimulated by either/both stretch and electrical stimulation in the extensor digitorum longus muscle of a rabbit.

>digitorum longus muscle

Wanna see my longus muscle, babe? ( ͡° ͜ʖ ͡°)

From the abstract itself, and my commentary:

Continuous electrical stimulation failed to change muscle protein turnover or growth.

Translation: Electrical stimulation of muscle itself doesn’t result in hypertrophy.

Static stretch caused significant adaptive growth, with increases in c-fos, c-jun, and insulin-like growth factor I (IGF-I; 12-fold) mRNA levels, and protein (19%), RNA (128%), and DNA (45%) contents. Both the fractional (138%) and total (191%) rates of protein synthesis increased with stretch, correlating with increased ribosomal capacities.

Important markers for muscle growth increasing due to stretching - IGF1 increasing 12x over baseline is significant, as is 191% increase in the rate of protein synthesis.

Combining stretch and electrical stimulation increased the mRNA concentration of IGF-I (40-fold). The adaptive growth was greater (35%), with massive increases in the nucleic acids (185 and 300%), ribosomal capacities (230%), and the rates of protein synthesis (345 and 450%).

Combined stretch and electrical stimulation increased IGF1 40x and protein synthesis 3-4x. Adaptive growth (+35%) refers to repair and growth of a muscle after being used.

Take-aways

Arnold was famous for posing between sets. Arnold believed that posing between sets allowed him to gain mastery over the muscles he was training and lengthen the individual muscles for more complete development. Lengthening the muscles, or stretching, is a parallel I see between the research and real life. As Arnold believed, combining stretching and contraction of the muscle seems to increase many of the important markers that support hypertrophy.

Unless you work out at home, I don’t think those in the gym would appreciate you posing in the mirror between sets. However, stretching between sets is unlikely to cause harm and if this research holds true in a real world setting (never a given) will support muscle growth.


r/PEDsR • • Mar 07 '21

RAD-150, aka TLB 150 Benzoate NSFW

35 Upvotes

I've been seeing more posts about RAD-150 recently, due to a recent ban on producing RAD-140 in China. Seems that to get around the ban, savvy suppliers have taken the RAD-140 compound and modified it slightly.

RAD-150, also known as TLB 150 Benzoate, has a very similar chemical structure as RAD-140.

  • Rad 140: 2-chloro-4-{[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino}-3-methylbenzonitrile

  • TLB 150 Benzoate: (2S,3R)-3-[(4-cyanophenyl)-1,3,4- oxadiazol-2-yl]-3-[(2-methyl- 3- chloro-4- cyanophenyl)amino]-2- propyl alcohol

However, while we have a buttload of studies on RAD-140, including human trials, we have nothing on RAD-150 aside from the claims of suppliers. Claims such as 'revolutionary', higher efficacy and the next step in SARM science are common. Even the name of RAD-150 seems to imply some kind of 'better' compound, like LGD-4033 v LGD 3033. But is any of that true?

No, or at least probably not. There's no studies on this stuff to really say. But what we do know is that RAD-150 is RAD-140 with a benzoate ester.

What is a Benozate Ester?

Benozate is the salt of benzoic acid. It's a benzene ring connected to an acid group, which when paired with an alcohol group such as found in RAD-140, reacts to form benzoate ester. An ester is what extends the half-life of a compound into something more practical.

Benozate esters are relatively short. It tastes pretty good, and are generally safe. It should be mostly bio available. It's most commonly found as an ester when combined with estradiol, where it has a half-life of 2-5 days.

The half-life or RAD-140 is around a day to begin with. Combining it with this ester will make the half-life of RAD-150 a couple of days at least.

So What?

It's impossible to make any claims about this being an improvement on RAD-140. More than likely, it has the same anabolic effects as RAD-140, takes a tiny bit longer to be effective, and takes longer to clear from the body. As we know, RAD-140 is highly effective. RAD-150 should be about the same.


r/PEDsR • • Sep 14 '19

Study Shows HGH + Others Reverse Epigenetic Aging in Humans NSFW

35 Upvotes

Disclaimer: I have no background in biology, chemistry, pharmacology, medicine etc. Any data presented is not advice, and I do not advocate the use of any illegal compounds. I have a potential conflict of interest: retail sale of related products.

Posted in the /r/science sub recently was a Nature article titled 'First hint that body’s ‘biological age’ can be reversed', within which is the claim scientists stumbled across a drug cocktail that reverses age. The Nature article was well written (albeit sensationalized) enough to gain some traction and the linked study just became available, several days after the article was published.

From the Nature article:

For one year, nine healthy volunteers took a cocktail of three common drugs — growth hormone and two diabetes medications — and on average shed 2.5 years of their biological ages, measured by analysing marks on a person’s genomes. The participants’ immune systems also showed signs of rejuvenation.

The 9 volunteers were aged 51-65 completed a study aimed at evaluating the use of HGH to re-grow the thymus, a gland that contributes to immune health. Coupled with HGH was DHEA and Metformin to limit the 'diabetogenic effect' of GH, presumably to reduce IGF1 as the increases that HGH would ordinarily cause 'might exacerbate cancerous or precancerous foci in the prostate'. It's important to note that both DHEA and Metformin have reportedly anti-aging effects, though Metformin certainly has its down sides too.

Results

Study available here: https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13028

Thymic regeneration DID occur in 7 of 9 subjects.

Baseline epignetic ages were decreased after 12 months by ~2.5 years, and a predictor of life expectancy (GrimAge) increased by 2.1 years

The TRIIM trial was designed to investigate the possibility of thymus regeneration and reversion of immunosenescent trends in healthy aging men while minimizing side effects and any possible risks. Our results support the feasibility of this goal but unexpectedly also bring to light robust evidence that regression of multiple aspects and biomarkers of aging is possible in man. These two observations may be related.

...

Thymus regeneration and reactivation by growth hormone administration have been established in aging rats and dogs by restoration of youthful thymic histology (Goff, Roth, Arp, & al., e., 1987; Kelley et al., 1986) and by reversal of age-related immune deficits (Kelley et al., 1986)

Doses

  • 50mg DHEA

  • 500mg Metformin

  • 0.015mg/kg HGH, or about 1.5mg

My presumption is that these doses are daily, and are what would be considered 'therapeutic'.

So What?

From purely a longevity standpoint, it's useful to see HGH (being used in conjunction with Metformin & DHEA) decreasing epigenetic age, with the assumption that this should translate into a longer life. Drawbacks of the study is the limited number of subjects (9 is not a large enough pool), and the age of the respondents. For example, would the same benefits apply to someone in their 20's, for example, or is it only effective in an older demographic? Does the Thymus have any role in longevity, or is this more a correlation and not causation? At any rate, grateful for the data and study, and generally interesting.


r/PEDsR • • Jun 26 '19

Quick (Personal) Update NSFW

35 Upvotes

Hey team, I've been away for the past few weeks/months. During this time, I've had a shift in personal viewpoints, and I'd like to share them, if you would permit.

When running a cycle, I historically have set a goal to achieve (such as bf, weight, % improvement on a key lift, etc.). Measuring these changes was how I determined if the cycle was successful or not. In the last 12 months, I've gone from a very clinical approach to running a cycle, to running a cycle for the sake of running a cycle... I'd say to myself, 'I've been off-cycle* for 4 weeks... what's my next one?', without ever really having a plan as to why I'd be running another one. Just some vague notion of asthetics, gains in strength etc.

*note, I was never really off-cycle. I'd always be using something to maintain muscle mass... be it MK677, YK11, whatever.

My wife turned to me just the other day and said 'whats' the goal here? Are you trying to get as big as Arnold? I don't want that'. I tell you bro's, that hit me hard. I have no goal in my PED use. Just getting bigger, faster, and/or stronger. That once I got bigger, faster and/or stronger, my life would somehow be better - women would be throwing themselves at me, men would respect me more, and my wife would finally get off my back about whatever she is nagging me about on that given day.

That's not to say there was no net benefit - there was an initial net gain in happiness when I was using PEDs. I needed less sleep, I could work longer, I had a better mood. I definitely looked better too. But there's a diseconomy of scale at work over time. And is it worth it, especially if there's no actual goal?

So with these thoughts as my catalyst, I spent some time in introspection, and came up with three items that I wasn't happy with:

  1. My personal involvement in the supply chain of compounds, coupled with my past advocacy of their use, would combine and lead me to legal issues. Accordingly, I've taken a different direction in my role in the supply chain. This is not a sourcing sub, so I'll post about that elsewhere.

  2. Personal long term cardiac and mental health issues from PED use. I've posted in the past about the incidence of cardiac and mental health issues, and I'm going to cover it again real soon. There's almost always a long-term effect to PEDs use. I want to get more real about this.

  3. /r/PEDsR becomes a gateway for activities that harm health... which is opposite of why PEDsR was created (putting aside broscience, testing assumptions, and minimizing harm). I've been very grateful for the alternate viewpoints we gather and index in /r/PEDsR. Moving forward, my own viewpoint will be far more neutral, advocating for safety first, and where possible advising folks to not use PEDs. Let me share you a related anecdote:

I had a young man reach out to me about a compound, asking some questions about its use. I knew this person reasonably well, as far as you can know anyone on Reddit or a Discord server. I knew where they were going to source this product and that the product would not be tested. Given they were ordering only a few vials at most, there was no way they were going to cough up the $250+ for their lab own test. The thought of him injecting himself with an untested product made me very uncomfortable. Unfortunately, I've seen firsthand the disregard that some suppliers have for their customers. Would someone ship this person tainted product? Absolutely they would and they wouldn't lose any sleep over it either. Did /r/PEDsR help convince this young man to use this compound? On the off chance that something went wrong, I'd definitely be upset, feel very guilty, and there's nothing I'd be able to do to be able to help.

Moving Forward

Folks are going to run PEDs pretty much regardless of anything anyone tells them. But as an important shift, I'm personally not going to be advocating any compounds use, providing personal use advice and where possible I'll provide detail on the safest alternatives.

I'm going to be doing my best to come off of PEDs, though I confess this is probably easier said than done. It's a bit like Pandoras Box... the demons are out. For those seeking ways out of PED use or are interested in my own plans, I'd be happy to write about that as well.

(P.S I've recently been watching a lot of Anabolic Doc (Dr. Thomas O'Connor) on YouTube. If you're not familiar with this guy, I recommend checking him out: https://www.youtube.com/channel/UCp3EQJtIdcyCVNASVN4UaYw. Dr. Thomas O'Connor covers compounds in an interesting way, talking about history, use, real-life examples of men he's treated that have used these compounds, and potential side effects. Note: his entire business is based around convincing men that PED use is bad, and helping them come off, so he may at times have a conflict of interest. He's not immune to making broad sweeping statements and not providing his sources, and I take issue with him in several topics he's covered. Otherwise, I find him interesting and usually accurate.)


r/PEDsR • • Apr 22 '19

Practical Examples of Making a Solution NSFW

34 Upvotes

One of the more frequently asked questions is how to take a powder and make a solution for convenient dosing. I have created 3 videos for your viewing pleasure:

  1. 1g compound to 50ml of PG - 20mg/ml Solution

  2. 500mg compound to 50ml of PEG-400 - 10mg/ml Solution

  3. 1g compound to 50ml of PEG-400 - 20mg/ml Solution

The videos show common variations on measuring, mixing, and storage. Each video description includes what items were used.

Guidance on Doses

CompoundSolventConcentrationVideoNotes
LGD-4033Propylene Glycol10mg/ml. 500mg to 50ml of PGReference https://youtu.be/bUe_pc_Kf3s but keep in mind that you will need a mg scale to weigh out the LGD-4033 rather than using the full amount like in the video
MK-2866Propylene Glycol20mg/ml. 1g to 50ml of PGhttps://youtu.be/bUe_pc_Kf3s
MK-677Propylene Glycol20mg/ml. 1g to 50ml of PGhttps://youtu.be/bUe_pc_Kf3s
YK-11Propylene Glycol10mg/ml. 500mg to 50ml of PGReference https://youtu.be/bUe_pc_Kf3s but keep in mind that you will need a mg scale to weigh out the YK-11 rather than using the full amount like in the video
GW501516PEG-40010mg/ml. 500mg to 50ml of PEG-400https://youtu.be/TZsDQMMaF4w
RAD-140PEG-40020mg/ml. 1g to 50ml of PEG-400https://youtu.be/H-IBiqY9Bcc
ITPPDistilled WaterNote that does for this compound tend to be ~300mg and can be weighed out on a mg scale, rather than making a solution
RU58841Propylene Glycol or Minoxidil solutionMaking Minoxidil / RU58841 Solution

Useful Links

FAQs

What to do if the compound does not mix fully (i.e. you're left with floating particles of compound in solution)?

  1. leave for 24 hours

  2. how water to outside of lidded bottle

  3. dilute solution

Why make a solution?

Easier and more accurate to dose.

Why not buy a premade solution?

There are many reputable vendors who sell premade solutions and it's always a valid option.

Making your own solution has two main benefits at the expense of convenience:

  1. Making your solution guarantees that your dose is accurate, or that at least you only have yourself to blame if you mess it up.

  2. Premade solutions are around ~3x more expensive per dose.

Are you aware that your dose isn't quite right? (And variations to this effect)

Agreed. I have tried to present this as simply as possible. While simply measuring 50mL of solvent and adding 500mg of solute introduces error (because adding the solid will change the final volume of the solution), it's a minor variation that does not concern most.